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Abstract 
The sesquiterpene (+)-zizaene is the immediate precursor of khusimol, the main compound of 
the vetiver essential oil from the vetiver grass, which grants its characteristic woody scent. 
Among its distinct applications, this oil is relevant for the formulation of cosmetics and used in 
approximately 20% of all men’s perfumery. The traditional supply of the vetiver essential oil had 
suffered shortages due to natural disasters. Consequently, the biotechnological production of 
khusimol is an alternative towards a more reliable supply. In this study, we provide new insights 
towards the microbial production of khusimol by characterizing the zizaene synthase, 
engineering the metabolic pathway of (+)-zizaene in Escherichia coli and analyzing the in situ 
recovery of (+)-zizaene from fermentation.  
In the first chapter, the zizaene synthase, the critical enzyme for khusimol biosynthesis, was 
characterized. A SUMO-fused zizaene synthase variant was overexpressed in E. coli, and in vitro 
reactions yielded 90% (+)-zizaene. Furthermore, enzyme characterization comprised enzyme 
kinetics, optimal reaction conditions, substrate specificity and reaction mechanisms. The in vitro 
reactions showed high stability through varying pH and temperature values. By in silico docking 
model, this was explained due to the hydrophobicity of the surrounding loops, which stabilized 
the closed conformation of the active site.  
The second chapter addressed the metabolic engineering of the (+)-zizaene biosynthetic pathway 
in E. coli. A systematic strategy was applied by modulating the substrate FDP and the zizaene 
synthase to improve the zizaene titers. The optimal (+)-zizaene production was reached by 
engineering the mevalonate pathway and two copies of the zizaene synthase into a multi-
plasmid strain. Optimization of the fermentation conditions such as IPTG, media, pH and 
temperature improved the production further, achieving a (+)-zizaene titer of 25 mg L‒1.  
In the third chapter, the in situ recovery of (+)-zizaene from fermentation was analyzed. Initially, 
liquid-liquid phase partitioning cultivation improved the (+)-zizaene recovery at shake flask 
scale. Subsequently, solid-liquid phase partitioning cultivation was evaluated by screening 
polymeric adsorbers, where Diaion HP20 obtained the highest recovery ratio. The bioprocess 
was scaled up to 2 L fed-batch bioreactors by integrating in situ recovery and fermentation. 
External and internal (with and without gas stripping) recovery configurations were tested, 
where the internal configuration obtained the highest (+)-zizaene recovery of all, achieving a (+)-
zizaene titer of 211.13 mg L−1 and a productivity of 3.2 mg L−1 h−1.  
 
Key words: (+)-zizaene, zizaene synthase, khusimene, khusimol, vetiver essential oil, 
Chrysopogon zizanioides, in situ product recovery, polymeric adsorbers. 
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Kurzfassung 
Das Sesquiterpen (+)-Zizaen ist der unmittelbare Vorläufer von Khusimol, der Hauptverbindung 
des ätherischen Öls aus dem Vetivergras, das seinen charakteristischen holzigen Geruch verleiht. 
Neben verschiedenen weiteren Anwendungen wird dieses Öl in ungefähr 20% aller 
Männerparfüme verwendet.  
Die traditionelle Versorgung mit ätherischen Ölen litt aufgrund von Naturkatastrophen unter 
Engpässen. Folglich ist die biotechnologische Herstellung von Khusimol eine Alternative für 
eine zuverlässigere Versorgung. In dieser Studie wird die mikrobielle Produktion von Khusimol 
charakterisiert, indem die Zizaensynthase charakterisiert, der Stoffwechselweg von (+)-Zizaen in 
E. coli bestimmt und die in situ-Gewinnung von (+)-Zizaen aus der Fermentation analysiert wird. 
Im ersten Kapitel wird die Zizaensynthase, das kritische Enzym für die Khusimol-Biosynthese, 
eingehend charakterisiert. Eine in E. coli überexprimierte SUMO-kondensierte Zizaensynthase-
Variante und in-vitro-Reaktionen ergaben 90% (+)-Zizaen. Weiterhin wurden 
Enzymcharakterisierung, optimale Reaktionsbedingungen, Substratspezifität und 
Reaktionsmechanismen analysiert. Die in vitro-Reaktion zeigte eine hohe Stabilität bei 
unterschiedlichen pH- und Temperaturwerten. Im silico-Docking-Modell wurde dies aufgrund 
der Hydrophobizität der umgebenden Schleifen erklärt, die die geschlossene Konformation des 
aktiven Zentrums stabilisierten. 
Das zweite Kapitel befasst sich mit dem metabolischen Engineering des                                   
(+)-Zizaen-Biosynthesewegs in E. coli. Eine systematische Strategie wurde angewendet, indem 
das Substrat FDP und die Zizaensynthase moduliert wurden, um den Zizaentiter zu verbessern. 
Die optimale (+)-Zizaen-Produktion wurde erreicht, indem der Mevalonat-Weg und zwei 
Kopien der Zizaen-Synthase in einen Multiplasmid-Stamm umgewandelt wurden. Eine weitere 
Optimierung der Fermentationsbedingungen wie IPTG, Medium, pH und Temperatur 
verbesserte die Produktion und erreichte einen (+)-Zizaen-Titer von 25 mg L-1. 
Im dritten Kapitel wurde die in situ-Gewinnung von (+)-Zizaen aus der Fermentation analysiert. 
Anfänglich wurde die Flüssig-Flüssig Extraktion für die (+)-Zizaen Gewinnung im 
Schüttelkolbenmaßstab untersucht. Anschließend wurde die Isolierung von (+)-Zizaene mit der 
Fest-Flüssig Extraktion untersucht, wofür polymere Adsorber gescreent wurden; Diaion HP20 
erzielte bei die höchste Produktivität. Der Bioprozess wurde durch Integration von in situ 
Gewinnung und Fermentation auf 2 l Bioreaktoren skaliert. Die höchste (+)-Zizaen  Gewinnung 
ergab in Ansatz mit direkter Adsorbersuspension während des Fermentation mit einem (+)-
Zizaen Titer von 211,13 mg L-1 und einer Produktivität von 3,2 mg L-1 h-1. 
Schlüsselwörter: (+)-Zizaen, Zizaensynthase, Khusimen, Khusimol, ätherisches Vetiveröl, 
Chrysopogon zizanioides, In-situ-Produktrückgewinnung, polymere Adsorber. 
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1. Introduction 
The vetiver essential oil (VEO) extracted from the roots of the vetiver grass Chrysopogon 
zizanioides, also called “Ruh-Khus”, is a “Perfume of its own right” [1], due to its pleasant dark 
woody scent, defined by Morris as “the gift of India to the world of perfumes” [2].  
The VEO is comprised by a complex mixture of components, mainly sesquiterpenes and their 
hydroxylated derivatives, which provides a viscous essential oil with a low volatilization rate, 
high solubility in alcohol, and is used for the formulation of the Majmua Indian perfume and in 
nearly 20% of men`s perfumes [1]. In the Western world, the VEO is the basis for many cosmetics 
such as Guerlain Vetiver, Chanel No. 5, Caleche and Parure. 
The traditional production of VEO is by steam distillation of vetiver roots of 1‒2 m in length and 
after 12‒18 months of cultivation. Commonly, the extraction rate is roughly 0.2‒3% by steam 
distillation and 4% by supercritical fluid extraction. The most important producers in the world 
are Haiti, Indonesia, India, China and Brazil with a world market size of 300‒350 tons per year.  
In recent years, the VEO supply has suffered shortages from its main producer, Haiti, due to 
earthquakes, floods and political unrest. Additionally, the extensive land use for the vetiver 
grass plantations has raised the environmental pressure due to the reduction of the natural 
forests. Consequently, the demand for VEO has risen considerably with an expected market of 
USD 169.5 million to be reached in 2022. To meet this demand, different alternatives are being 
considered to produce the aromatic compounds of VEO and mimic its woody smell. Among 
others, khusimol, α-vetivone and β-vetivone are the main fragrant sesquiterpenes which have 
not yet been produced successfully by traditional chemical synthesis. Therefore, the production 
of khusimol by metabolically engineered microorganisms has gained interest from the cosmetic 
and academic sector; this is especially because khusimol is the main constituent of VEO and it 
grants the characteristic woody vetiver note.  
Recent advances in the engineering of the mevalonate (MEV) and methylerythritol phosphate 
(MEP) pathway, as well as current progress in the heterologous expression and characterization 
of terpene synthases have made possible the industrialized production of terpenes. As an 
example, the high-valued cosmetic oil squalane is produced by a semi-biotechnological process, 
through the microbial production of the precursor β-farnesene, which is further chemically 
hydrogenated to squalane. Such a strategy has proven valuable because the traditional source of 
squalane originates from shark livers, and it has raised great concern by environmental 
authorities.  
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Similar to the squalane production strategy, the production of the direct precursor of khusimol, 
the tricyclic sesquiterpene (+)-zizaene, could also be achieved by a biotechnological process and 
then, further hydroxylated to khusimol. This process could be advantageous by reducing the 
production costs using an economical carbon source. Moreover, it could provide a reliable and 
sustainable supply of fragrant sesquiterpenes through all the seasons to the cosmetic industry 
from renewable resources.  
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2. Scope of the investigation 
The main goal of this dissertation is to provide new insights from basic to applied research in the 
production of (+)-zizaene by a microbial platform towards the production of the fragrant 
sesquiterpene khusimol.  
As a starting point, the first specific goal is to characterize the zizaene synthase by biochemical 
methods to build the basis towards the metabolic engineering of (+)-zizaene. This enzyme is 
crucial in the (+)-zizaene biosynthesis and the enzymology study will comprise the enzyme 
kinetics, reaction conditions, substrate specificity, reactions mechanisms and catalytical 
conformation changes.  
The second goal is to engineer the metabolic pathway of (+)-zizaene in E. coli as host by 
optimizing the FDP and zizaene synthase pathway to improve the (+)-zizaene titers. 
Additionally, the study will optimize the fermentation conditions and evaluate distinct E. coli B 
strains to further improve the (+)-zizaene titers. 
The last goal is to integrate the in situ product recovery and fermentation by different fed batch 
bioreactor configurations to enhance the microbial production of (+)-zizaene. For that, the loss of 
(+)-zizaene by volatilization will be initially studied, as well as the liquid-liquid phase 
partitioning cultivation. Moreover, distinct polymeric adsorbers will be screened and the (+)-
zizaene recovery will be measured. Finally, distinct bioreactor configurations will be tested at 2 L 
stirred-tank bioreactor scale with integrated in situ product recovery. 
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3. Theoretical background 
3.1. General aspects of isoprenoids 
Isoprenoids are the largest family of natural products, consisting of more than 40,000 molecules, 
structured as hydrocarbon skeletons and their oxygenated derivatives as alcohols, lactones, 
aldehydes and ketones [3,4]. The term “terpene” originates from the studies of Otto Wallach 
(1847-1931), who studied the components of pine tree resins from and observed that the thermal 
decomposition of turpentine and derived monoterpenes yielded the basic C5 “isoprene unit” (2-
methyl-1,3-butadiene) [5]. Isoprenoids, also called terpenoids or terpenes, are synthesized by the 
condensation of C5 isoprene units from head-to-tail, also referred as the “isoprene rule“ defined 
by Leopold Ruzicka in 1953, in which terpenes diversify into hundreds of hydrocarbon 
structures (Figure 1) [6].  
 
Figure 1. Terpene structures originating from C5 isoprene unit blocks diversify into numerous 
variants with broad industrial applications.  
There are few terpenes that display a linear head-to-tail structure as depicted in Figure 2, 
whereas triterpenes and tetraterpenes are condensed from two units of sesquiterpene and 
diterpenes respectively in a tail-to-tail fashion. In most of the cases, terpenes are structured as 
non-linear cyclic hydrocarbons to deliver an assortment of complex and stereo-specific 
arrangements [7].   
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Figure 2. Building of terpenes by condensation of isoprene units according to their family. Blue 
bonds: Head-to-tail. Red bonds: Tail-to-tail [7]. 
Terpenes are classified into 6 families according to their number of isoprene units and carbon 
atoms, which in turn defines the specific terpene prefix, as shown in Table 1. The prenyl 
transferases are responsible for the specific number of isoprene units for each terpene family, by 
catalyzing with great specificity a particular prenyl diphosphate for each terpene family [8]. 
 
Table 1. Isoprenoid families according to their isoprene units and precursors. 
Terpene 
Prefix 
Carbon 
Atoms 
Isoprene 
units 
Terpene 
Precursor 
Synthase 
Class 
Hemi- 5 1 IPP/DMAPP I 
Mono- 10 2 GDP I 
Sesqui- 15 3 FDP I 
Di- 20 4 GGDP I,II 
Tri- 30 6 FDP II 
Tetra- 40 8 GGDP II 
Underlined terpene precursors are built by condensing 2 units of specific prenyl diphosphates. 
3.2. Terpene biosynthesis 
The biosynthesis of isoprenoids can be divided into four stages, starting from the glycolysis, 
which converts either C5 or C6 sugars, such as glucose, yielding the intermediates glyceraldehyde 
3-phosphate (GAP), pyruvate and acetyl-CoA [4] (Figure 3). Eventually, these compounds are 
required for other metabolic routes such as the TCA-cycle for acetyl-CoA. However, these 
intermediates are crucial for terpene biosynthesis and are the starting point of the second 
biosynthetic stage by two independent pathways, the mevalonate (MEV) pathway and the 
methylerythritol phosphate (MEP) pathway [9].  
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The MEV-pathway was the first characterized pathway for terpene biosynthesis and it is 
ubiquitous in the cytosol of eukaryotic cells [9]. The starting point is acetyl-CoA, which is 
catalyzed through an enzymatic cascade by acetoacetyl-CoA thiolase (AACT), 
hydroxymethylglutaryl-CoA synthase (HMGS) and hydroxymethylglutaryl-CoA reductase 
(HMGR) to yield mevalonate. Further processing by mevalonate kinase (MK), 
phosphomevalonate kinase (PMK), and mevalonate diphosphate decarboxylase (MPDC) leads to 
the isoprene unit precursors isopentenyl diphosphate (IPP), which is isomerized to dimethylallyl 
diphosphate (DMAPP) by the isopentenyl diphosphate (Idi) [10].  
On the other hand, the MEP-pathway was characterized in the early 90s by Rohrmer and co-
workers [11], and is found in prokaryotes and plant plastids. The MEP-pathway requires two 
initial intermediates, GAP and pyruvate, which are condensed by the deoxyxylulose phosphate 
synthase (Dxs) to yield 1-Deoxy-D-xylulose 5-phosphate (DXP). Furthermore, DXP is catalyzed 
by the reductoisomerase (Dxr) to yield 2-C-Methyl-D-erythritol 4-phosphate and undergoes 
further into a multi-enzyme reaction (MCT, CMK, MDS, HDS and HDR) that leads to the 
formation of IPP and DMAPP [12].  
In phototrophic organisms, both MEP and MEV-pathways converge for the exchange of 
IPP/DMAPP and other intermediates by a dynamic cross-regulation or crosstalk from plastids to 
cytoplasm and vice versa [10].  
 
MEP-pathway:  1 Glucose + 2 ATP + 2 NADPH             1 IPP + CO2  (1) 
(YIPP/Glucose = 0.83 mol/mol of carbon) 
 
MVA-pathway:  1.5  Glucose           1 IPP + 4 CO2 + 3 NADPH       (2) 
(YIPP/Glucose = 0.56 mol/mol of carbon) 
 
When comparing both pathways, the MEP-pathway is more efficient than the MEV-pathway for 
carbon utilization, disregarding metabolism energetics, whereas 1 mol of glucose yields 1 IPP 
and with a higher carbon theoretical yield of 0.83 c mol/c mol (Equations 1 and 2) [13]. On the 
contrary, MEV-pathway is more efficient than the MEP-pathway in terms of energetics by 
producing NADPH and NADH. Consequently, both pathways are relevant and plants 
commonly use both pathways to respond promptly to environmental changes [14]. 
The third stage for terpene biosynthesis is the catalyzation of the isoprene units IPP/DMAPP to 
yield the basic terpene substrates. For that, DMAPP is condensed by prenyl transferases with one 
or more units of IPP, which leads to prenyl diphosphates of distinct isoprene chain lengths [13].   
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Figure 3. Biosynthetic pathway of terpenes in plant cells initiating from glucose to terpenes, divided 
into four stages: glycolysis (grey circles); MEP and MEV-pathway (green and blue circles); 
diphosphate prenylation for terpene substrates (red circles); terpene catalyzation by TPS (purple 
circles).  
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According to Figure 3, prenyl transferases catalyze the formation of terpene substrates: geranyl 
diphosphate (GDP)(1 DMAPP + 1 IPP), farnesyl diphosphate (FDP)(1 DMAPP + 2 IPP) and  
geranylgeranyl diphosphate (GGDP)(1 DMAPP + 3 IPP). 
The last stage comprises the most variable and broad step, where terpene substrates are 
catalyzed by metal-dependent terpene synthases (TPS) for the formation of hundreds of acyclic 
and cyclic terpene variants. In detail, prenyl diphosphate substrates bind to metal ion cofactors, 
mostly Mg2+, that are bound to aspartate rich motifs positioned in the docking site of the TPS 
[15]. The isoprenoid diphosphate substrate undergoes ionization and the prenyl tail is cleaved 
from the diphosphate moiety (PPi) and is pulled into the active site cavity of the TPS. Hereafter, a 
series of carbocations takes place as the aromatic rings from the active site chaperone 
stereospecific rearrangements such as alkyl and methyl shifts until quenching occurs by 
deprotonation, resulting in a vast variety of terpene structures [16].  
In addition, monoterpene and sesquiterpene synthases are characterized with the class I fold in 
the α-helix, whereas diterpenes synthases include the class I and/or class II folds in the α and β 
helices respectively [17]. In consequence, the condensation of 2 units of FDP yields the formation 
of  C30 triterpenes and 2 units of GDP lead to C40 tetraterpenes [18].  
Terpenes can undergo further modifications such as hydroxylations by cytochrome P450 
monooxygenases. In plants, these membrane enzymes are anchored in the endoplasmic 
reticulum (ER) and operate together with cytochrome reductases and cofactors such as flavin 
adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to provide a reducing 
regeneration system through a NADPH or NADH supply [19].  
3.3. Biological roles of terpenes 
Terpenes are found in all living organisms; however, they are found predominantly in the plant 
kingdom, functioning as primary and secondary metabolites. Primary metabolism terpenes are 
related to plant growth functions (cell division, elongation and inhibition), like plant hormones, 
which include gibberellins (C20), brassinosteroids (C30), abscisic acid and strigolactones [20].  
Due to their structural variety, terpene elements, like isoprene C5 units, form part of the structure 
of many natural products such as vitamins, phenolics and alkaloids [5]. Likewise, cytokinins are 
formed of an isoprene C5 unit side chain; abscisic acid is synthesized originally from a 
sesquiterpene backbone and strigolactones are the product of the cleavage of diterpene 
carotenoids [20]. Moreover, terpene elements can decorate proteins with long linear farnesyl or 
geranylgeranyl chains that bind to cysteine residues, enhancing the molecules’ hydrophobicity 
and serve as transport tags to anchor into cell membranes [6].  
Despite the importance of primary metabolism terpenes as structural elements, secondary 
metabolism terpenes play a critical role for plant interaction with the environment and enable 
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plants to respond properly to biotic and abiotic stresses [4]. A case for abiotic stress is isoprene, 
which protects leaves against high temperatures due to ozone-induced oxidative damage in 
tobacco plants [21]. Similarly, carotenoids (C40), which are red, orange or yellow pigments, are 
involved in tissue protection against oxidation due to high light exposition by preventing the 
accumulation of damaging radical oxygen species (ROS) [22]. An additional function of 
carotenoids is to attract insects to flowers for further pollen dispersal [22]. Nevertheless, most 
terpenes are recognized for their role against biotic stresses such as phytopathogens due to their 
antimicrobial properties [23]. Thus, terpenes are produced in most of the plant organs as the first 
line of defense; consequently, there are many reports of terpenes as insecticides, bactericides, 
fungicides, and nematicide as described in Table 2.  Due to their volatile properties, terpenes are 
well known natural products for flavors and fragrances, which in nature play an important 
function as signals for communication within plants, to repel dangerous insects, or to attract 
predatory insects against other harmful insects [23].  
 
Table 2. Biological roles of selected terpenes from plant origin  
Function Plant organ Terpene Plant Reference 
Abiotic stress     
Light and thermal 
protection 
Leaves Isoprene Populus alba [21] 
Light and thermal 
protection 
 
Leaves Zeaxanthin 
 
Hordeum vulgare [24] 
Biotic stress     
Insecticide Seeds Azadiractin Azadirachta indica [20] 
Insecticide Foliar trichomes Menthol and neomenthol Mentha x piperita L.  [25] 
Insecticide Roots Rhizathalene Arabidopsis thaliana [26] 
Bactericide Flowers  (E)-β-Caryophyllene Arabidopsis thaliana [27] 
Fungicide Leaves Cineole and citronellol Eucalyptus globulus and  
E. citriodora 
[28] 
Repellent Foliar trichomes E-β-farnesene Solanum berthaultii [29] 
Repellent Leaves (S)-Linalool Fragaria x anannasa 
cv. Elsanta 
[30] 
Flavoring  Leaves Geraniol Ocimum basilicum  
L. cv. Sweet Dani 
[31] 
Attract pollinators Flowers S-linalool and 
8-hydroxylinalool 
Clarkia breweri [32] 
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3.4. Industrial application of terpenes 
Terpenes are used currently in numerous applications in different industrial sectors. The 
pharmaceutical industry uses terpenes as active pharmaceutical ingredients (API) such as taxa-4, 
11-diene, perillyl alcohol, zerumbone and geraniol for the formulation of pharmaceuticals. 
Likewise, the terpenes isoprene and α/β-pinene are used for rubber and resin precursors 
respectively for the chemical industry.  
Due to their pesticide properties, many terpenes are used in agriculture for organic control, such 
as limonene (insecticide), geraniol (repellent), farnesene (aphid repellent), linalool (predator 
attractant), and E-β-caryophyllene (pathogen resistance) [27].  
Terpenes such as β-farnesene, are used recently as renewable fuel for the airplane industry, 
which is produced by microbial platforms [33]. The most notorious application of terpenes is for 
flavors and fragrances by using essential oils or purified terpenes such as limonene, menthol, 
eucalyptol, nootkatone and applying them in house-cleaning and cosmetic formulations    
(Figure 1) [23].  
3.5. Essential oils in the cosmetic industry 
The cosmetic industry is a broad market consisting of diverse products such as color cosmetics 
(make-up), skincare, hair care, hygiene products, men´s grooming, and fragrances, reaching a 
global market of USD 525.33 billion for 2018 and with an expected growth for cosmetic 
ingredients of USD 26.8 billion for 2020 [34].  
Essential oils represent an important share for cosmetic ingredients in which 29% of the total 
essential oil production is directed for fragrances, aromatherapy and cosmetic ingredients; 
holding a global market of USD 6 billion for 2017, with an expected growth of USD 10 billion for 
2020 [35]. The most economically relevant essential oils in the worldwide market are orange, 
corn mint, eucalyptus and peppermint [36].  
An important share of the essential oils market is directed towards the formulation of perfumes 
due to their fragrant volatiles. Essential oils are constituted of lipophilic and non-polar 
molecules, mainly fragrant terpenes, and are used at low concentrations in perfume formulations 
[37].  Consequently, each essential oil grants a specific scent note to the formulation; whereas top 
notes are light scents lasting 5‒10 min, middle notes grant prominent scents lasting several hours 
and base notes bring deeper fragrances and last the longest [38]. 
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Table 3. Essential oils of plant origin used in perfumery according to their scent note [38]. 
Top note Middle note Base note 
Basil Black pepper Amyris 
Bergamot Cassia Lavender 
Citronella Chamomile Balsam 
Coriander Cinnamon Cedarwood 
Eucalyptus Clove Jasmine 
Ginger Cypress Myrrh 
Lemon Marjoram Patchouli 
Orange (Neroli) Pine Rosewood 
Peppermint Rose Sandalwood 
Spearmint Rosemary Vetiver 
Tea tree Thyme Ylang ylang 
 
The Table 3 summarizes the most important essential oils used for perfume formulations in the 
cosmetic industry. In addition, individual fragrances (purified terpenes) are applied also in 
perfume formulations, for example, bisabolol, carvone, farnesol, geranial, geraniol, linalool, 
limonene, and menthol [37].   
3.6. Vetiver essential oil 
The vetiver essential oil (VEO) is one of the oldest and most significant essential oils in fine 
perfumery, characterized  as a dark, grapefruit, earthy, woody scent, and used as base note for 
more than 37% of Western perfumes and 20% of men’s perfumes, including Chanel No. 5, 
Guerlain Vetiver, Berdoues 1902 Trèfle & Vétiver, Caleche, Opium, Parure, Dioressence and 
Vetiver extraordinaire [1]. In 2018, the global production of VEO was estimated at 300–350 ton 
per year [39] with prices oscillating between USD 380–500 per kg [40]. Due to the increase in the 
cosmetic demand, the world market of VEO is expected to grow to USD 169.5 million for 2022 
[41]. The main producers worldwide are Haiti (100 t/year), Indonesia (80 t/year), China (20 
t/year), India (20 t/year), Brazil (15 t/year) and Madagascar (0.5 t/year) [42].   
VEO is obtained from the vetiver grass, Chrysopogon zizanioides (Poaceae), which is native to 
north India. Ch. zizanioides is a tufted perennial grass with 80 cm long bladed-elongated leaves 
branching basally from clumps, with a massive-deep root system (Figure 4) [43]. VEO is 
extracted from mature roots of 1–2 m of length and harvested after 12–18 months of growth. The 
most common extraction method is steam distillation that yields approximately 0.2–3% [42], and 
by super-critical fluid extraction, the extraction yield can be increased up to 4% [44]. Eventually, 
yields depend on the extraction method, but also from agronomical factors such as cultivars, 
weather, soil and fertilization. 
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Figure 4. Right: Foliage and roots of the vetiver grass Ch. zizanioides. Left: Traditional steam 
distillation facility for VEO production [45].  
The chemical composition of VEO is a complex mixture of more than 300 molecules, mostly 
sesquiterpenes, and its oxygenated derivatives in which khusimol, α-vetivone, β-vetivone and 
isovalencenol are the main constituents (Figure 5) [42,46]. Although olfactory analyses are 
variable, the khusimol and zizaane derivatives grant the classical woody vetiver note,                 
β-vetivone confers a grapefruit scent, α-vetivone provides a citrus rosy lime note and 
isovalencenol lends a strong sandalwood scent [47].  
However, VEO composition differs from the origin of production, wherein “normal” VEO is 
produced by a sterile vetiver grass cultivar. Moreover, its composition includes additionally 
vetivane, zizaane, eremophilane and eudesmane derivates, which are the main VEO on the 
market, produced by Haiti, Indonesia, China, Brazil and South India [42,48]. Normal VEO is 
characterized by a dextrorotatory character with woody, smoky-earthy notes with a long-lasting 
scent due to the low rate of volatility [42,46]. The Bourbon VEO produced from La Réunion 
contains roseate notes and is considered of high quality [1].  
 
 
Figure 5. Main sesquiterpene structures contained in the “normal” VEO and their abundance. 
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The VEO produced by the fertile vetiver grass cultivar in northern India, called “khusoil”, is a 
highly regarded oil and lacks vetivones, containing high amounts of khusinol and khusilal 
(cadinanes derivatives) and is characterized by a balsamic woody notes with a levorotatory scent 
[1,42]. 
3.7. The fragrant sesquiterpene Khusimol  
Recent interest has increased for the biotechnological production of fragrant sesquiterpenes from 
the VEO, to be used as individual fragrances and replace the VEO supply, which has lately 
suffered important shortages. This situation has increased from its main producer Haiti in the 
production area of Les Cayes, formerly due to natural disasters such as earthquakes and floods 
[40], and currently due to political unrest. This has resulted in shortages of the fuel supply 
required for the operation of VEO distilleries and transport of goods, resulting in the 
impossibility to extract VEO from fresh material and delaying the exports of the final product 
[45]. Of special importance is the fragrant sesquiterpene khusimol, the most abundant 
constituent of VEO, which grants a woody vetiver note [47].  
Like most sesquiterpenes, the khusimol biosynthesis initiates from the sesquiterpene substrate 
FDP, which is catalyzed by a metal-dependent class-I fold TPS called zizaene synthase (ZS). This 
is the central enzyme for the khusimol biosynthesis, catalyzing FDP through distinct carbocation 
rearrangements and cyclizations to yield the tri-cyclic (+)-zizaene (syn. khusimene). 
Furthermore, (+)-zizaene is hydroxylated by a cytochrome P450 monooxygenase, accompanied 
by a cytochrome reductase and FMN/FAD cofactors, which leads to khusimol as main product. 
The hydroxylation reactions also yield zizaane oxygenated derivatives such as zizanal and 
zizanoic acid as side products (Figure 6) [49]. 
 
 
Figure 6. Biosynthesis of khusimol initiating from the sesquiterpene substrate E,E-FDP. 
Hydroxylation modifications are indicated in green color. 
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3.8. The direct-precursor of khusimol, (+)-zizaene 
In an effort to produce khusimol as an individual fragrance, the production of the direct 
precursor (+)-zizaene has been the subject of study, comprising its chemical synthesis, 
enzymology and biotechnological production. The first stereocontrolled total synthesis of         
(+)-zizaene was described by Coates et al. [50], using as initial material norcamphor, which 
undergoes different arrangements, reductions and oxidations to yield a racemic mixture of      
(±)-zizaene. Piers et al. [51] developed a new formal total synthesis of (±)-zizaene starting from  
β-iodo enones, yielding a 2:1 epimeric mixture of the sesquiterpene. Another stereocontrolled 
total synthesis approach was developed by Chandra Pati et al. [52], initiating from indanone 
through a base induced pinacol type rearrangement as a key step, followed by a Wittig 
olefination.  
However, the industrialization of the production of (±)-zizaene by chemical synthesis is 
challenging due to the costs associated with the multiple reactions and the toxicity of harmful 
chemicals. Hence, the production of (+)-zizaene by green chemistry methods such as enzymatical 
biotransformations or whole-cell based systems could solve the shortcomings from the chemical 
synthesis to yield a stereospecific (+)-zizaene at a lower production cost. An important milestone 
for the production of (+)-zizaene was achieved in 2014 by the cloning, overexpression and 
characterization of the native ZS gene, obtained from Ch. zizanioides [53]. In both in vitro and in 
vivo production systems, the terpene profile demonstrated 60-90% (+)-zizaene as main product, 
and pre-zizaene, α-funebrene and β-funebrene as side products [53].  
Furthermore, a recombinant variant of the ZS gene was engineered with a small ubiquitin-
related modifier (SUMO) as a fusion domain on the N-terminal end [54]. Such SUMO-fused ZS 
variant improved the solubility when compared to that of the native ZS version when 
heterologously overexpressed in E. coli. Furthermore, the in vitro biotransformation of E,E-FDP 
with the SUMO-fused ZS produced a different product profile than the native ZS version by 
lacking the funebrene side products [54]. 
3.9. Production of fragrant terpenes by metabolically engineered microorganisms  
The production of fragrant terpenes by metabolically engineered microorganisms provides an 
alternative towards a cost-effective, reliable, environmentally friendly and sustainable 
production system from renewable sources, independent from environmental conditions [55,56].  
Two important milestones have contributed to the engineering of isoprenoids into microbes: the 
elucidation and engineering of terpene biosynthetic pathways and the heterologous 
overexpression and characterization of plant TPS. Additionally, progress in synthetic biology 
tools has also contributed importantly to the development of terpene-producing strains, for 
example, genome sequencing technologies, bioinformatics tools, expanding omics databases, 
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tailoring of codon-optimized synthetic genes and improved PCR-based gene cloning methods 
[57,58]. 
The engineering of the MEV-pathway into microorganisms in the early 2000s by Keasling and 
co-workers [59] revolutionized the isoprenoid engineering by constructing a MEV-pathway into 
two operons (MevT and MBIS) with genes originating from E. coli and Saccharomyces cerevisiae, 
improving significantly the amorpha-4,11-diene titers. Since then, it has been applied for the 
engineering of numerous terpenes in combination with enhanced versions of the MEP-pathway, 
employing variants of the DXS and DXR genes, and heterologous prenyl transferases, as 
demonstrated for the production of valerenadiene and longifolene [60,61].    
In addition to these developments, more than 100 monoterpene and sesquiterpene synthases 
genes of plant origin have been overexpressed in microbial hosts and characterized as reviewed 
elsewhere [62], which is a critical asset to the engineering of terpene biosynthetic pathways in 
microorganisms, commonly into E. coli or yeasts.  
3.10. Downstreaming of terpenes  
The recovery of terpenes from the fermentation of metabolically engineered microorganisms 
requires special considerations due to their non-polar and hydrophobic nature [63]. Thus, 
terpenes can be degraded by microbial strains or volatilized, which is increased in bioreactors by 
the gassing of air. Depending on their hydrophobicity, terpenes can be highly toxic to microbial 
cells, in which terpenes with low log P values usually partition to microbial cell membranes, 
altering the cell integrity and metabolic functions [64]. To overcome such drawbacks, in situ 
product recovery (ISPR) is applied commonly in terpene fermentation by removing products 
during cultivation [65].  
ISPR techniques can be implemented whether by liquid or solid extractants that trap the terpenes 
due to hydrophobic interactions or adsorption, and avoid their volatilization. Thus, the liquid-
liquid phase partitioning cultivation (LLPPC) utilizes organic solvents as extractants, resulting in 
an aqueous phase (media and cells) and organic phase (terpenes and solvents) in the 
fermentation [63]. The organic solvents are usually bio-compatible with cells and have high log P 
values [66]. The solid-liquid phase partitioning cultivation (SLPPC) uses zeolites, activated 
carbon, or polymeric adsorbers as solid extractants, in which terpenes are selectively adsorbed 
from fermentation [67]. Afterwards, desorption of terpenes is performed by eluting the solid 
extractants with a suitable organic solvent.  
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Figure 7. Configurations for in situ product recovery of terpenes in bioreactors. (A) Extractants in 
direct contact inside the vessel. (B) Extractants inside an EBA in direct contact by an external loop.     
(C) Extractants inside a gel matrix (dark grey) or separated from culture by a membrane without cell 
contact. (D) Extractants inside an EBA without cell contact by a perfusion external loop. Light grey 
color indicates cells and media. Modified from Buque-Taboada [68], Freeman [69] and Schewe [63]. 
The ISPR can be integrated to bioreactors using different basic configurations, classified into two 
variables: contact of extractant (direct or indirect) and localization of extractant (internal or 
external) as shown in Figure 7. In the direct contact, the extractant is in contact with the cells and 
media, whereas the indirect mode, the extractant is in contact with the cell-free broth through a 
perfusion unit. In the internal recovery configuration (IRC), the extractants remain inside the 
bioreactor vessel, either dispersed [70] or inside an internal basket [71]. In contrast, in the 
external recovery configuration (ERC), the culture broth is recirculated to an external loop with 
an expanded bed adsorption (EBA) unit, enabling a semi-continuous recovery of the product 
[65,72]. Consequently, the configuration of choice is dependent on the chemical properties of the 
terpene and the production costs [68]. 
As a result of the advances in both metabolic engineering and downstreaming of isoprenoids, 
many terpene bioprocesses have reached industrial levels and are currently marketed for the 
following applications: pharmaceutical: artemisinin; biofuel: β-farnesene; cosmetic ingredient: 
squalane; fragrance: nootkatone, patchouli oil, sclareol and valencene [13,33,73,74]. 
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4. Experimental research 
This section includes the experimental investigation for the study of the sesquiterpene              
(+)-zizaene from basic to applied research by investigating the zizaene synthase enzymology, the 
microbial production and recovery of (+)-zizaene. 
Consequently, the experimental research is divided into three research articles. The first chapter 
addresses the enzymology of the critical enzyme in the biosynthesis of (+)-zizaene, the zizaene 
synthase. This study comprises the product profile, enzyme kinetics, optimization of the reaction 
conditions, catalytical specificity, reaction mechanisms and conformational changes during 
catalysis. 
The second chapter deals with the metabolic engineering for the production of (+)-zizaene in       
E. coli. Hence, distinct constructs were tested to modulate the supply of the precursor FDP and 
the zizaene synthase to enhance the (+)-zizaene levels. In addition, the optimization of the 
fermentation conditions was studied to further improve the (+)-zizaene amounts. 
The third and last chapter applies the basic knowledge gathered from the initial chapters to 
scale-up the (+)-zizaene production at bioreactor scale and to further improve the (+)-zizaene 
titers. For that, the integration of fermentation and in situ product recovery was addressed by 
polymeric adsorbers and distinct bioreactor configurations were evaluated. 
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CHAPTER 1 
 
 
Catalytical specificity, reaction mechanisms, and conformational 
changes during catalysis of the recombinant SUMO (+)-zizaene 
synthase from Chrysopogon zizanioides 
 
 
 
 
 
 
Chapter published in: Aguilar, F.; Hartwig, S.; Scheper, T.; Beutel, S. Catalytical specificity, reaction 
mechanisms, and conformational changes during catalysis of the recombinant SUMO (+)-zizaene 
synthase from Chrysopogon zizanioides. ACS Omega 2019, 4, 6199‒6209. DOI:10.1021/acsomega.9b00242 
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4.1. Catalytical specificity, reaction mechanisms, and conformational changes during 
catalysis of the recombinant SUMO (+)-zizaene synthase from Chrysopogon zizanioides 
The VEO is an important fragrant ingredient for the cosmetic industry and used in nearly 20% of 
all men’s perfumes. The main compound of this essential oil is the sesquiterpene khusimol, 
which grants the characteristic dark woody smell. The biotechnological production of khusimol 
has raised interest for its potential to replace the traditional supply of VEO, which had suffered 
shortages from its main producer, Haiti, due to natural disasters and political unrest.  
For the development of a biotechnological process of khusimol, understanding the biosynthetic 
pathway is paramount. The critical enzyme for the biosynthesis of terpenes is the TPS which 
catalyzes the naturally occurring substrate E,E-FDP to yield products with high specificities. For 
the khusimol biosynthesis, the ZS is the TPS, where its characterization and optimal 
overexpression can provide the basis for the metabolic engineering towards khusimol. 
In this chapter we address a further enzymatic characterization of the ZS by analyzing the 
enzyme kinetics, in vitro catalytical reactions, substrate specificities, reactions mechanisms and 
docking model.  
Initially, we analyzed the terpene profile from in vitro biotransformation reactions with the 
substrate E,E-FDP and the recombinant SUMO-fused ZS variant, which was produced from       
E. coli and constructed from a previous report [54]. The in vitro reaction yielded over 90%         
(+)-zizaene and 8.5% β-acoradiene as side product. Furthermore, the reaction conditions of the 
biotransformation reaction were optimized, where pH 7.5 and temperature 36 °C were found as 
optimal. Additionally, enzyme kinetics was studied under optimal reaction conditions, where ZS 
catalysis followed a substrate inhibition kinetic model. 
Catalytic specificity was also evaluated by monoterpenes substrates GPP and NPP that led to a 
variety of cyclic, acyclic and hydroxylated monoterpenes. Sesquiterpene substrate isomers      
E,Z-FDP and Z,E-FDP were additionally tested, yielding β-Z-farnesene by E,Z-FDP and  Z,E-FDP 
led to a similar profile as E,Z-FDP but with the addition of β-E-farnesene and β-acoradiene. 
Consequently, the ZS demonstrated promiscuity for monoterpenes substrates but a high fidelity 
towards sesquiterpene substrates.  
Furthermore, the reaction conditions with E,E-FDP were studied under a wide range of 
temperature and pH values, revealing minimal changes in the product profile that suggests a 
strong and stable closed conformation during catalysis. To understand such behavior, the 
conformational changes during catalysis were studied via an in silico docking model. 
Interestingly, the surrounding loops from the active site (J-K and A-C loop) were constituted of 
neutral and hydrophobic residues, which grant stability against pH changes from the reaction 
buffer.  
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Moreover, distinct residues from the J-K loop could be involved in the efficient sealing of the 
active site, stabilizing the closed conformation against dynamic fluctuations that occur at higher 
temperatures. 
Accordingly, this study demonstrated new insights concerning the enzymology of the ZS and 
builds the foundations towards the metabolic engineering of the (+)-zizaene biosynthetic 
pathway. 
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ABSTRACT: Zizaene synthase (ZS) from Chrysopogon
zizanioides (Poaceae) is the critical enzyme in the biosynthesis
of the fragrant sesquiterpene khusimol, a major component of
the vetiver essential oil used widely by the cosmetic industry. As
reported previously, we heterologously and successfully ex-
pressed the active ZS with a small ubiquitin-related modifier
(SUMO) fusion domain. In this study, we report the
optimization of reaction conditions and determination of
enzyme kinetics of ZS. Moreover, we investigate the catalytic
specificity and reaction mechanisms with the ubiquitous
(2E,6E)-farnesyl diphosphate (FDP) and with C10 and C15
prenyl diphosphate isomers. Catalytic promiscuity occurs with
monoterpene substrates generating eight products that
comprise acyclic, cyclic, and hydroxylated monoterpenes. In contrast, ZS is a high-fidelity terpene cyclase when used with
C15 isomer substrates, yielding as major products (Z)-β-farnesene (100%) for (2E,6Z)-FDP and (+)-zizaene (81.7%), β-
acoradiene (12.8%), and (E)-β-farnesene (5.5%) for (2Z,6E)-FDP. Cyclization of the ubiquitous substrate (2E,6E)-FDP
demonstrates a higher catalytic specificity, whereas the reaction proceeds via the acorenyl cation that generates (+)-zizaene
(91.5%) and β-acoradiene (8.5%). Furthermore, catalytic specificity with (2E,6E)-FDP was stable in reactions tested at distinct
pH and temperatures, suggesting a stable and efficient closed conformation of the active site during catalysis. To understand
such stability, open and closed structural conformations of ZS were modeled in silico and revealed putative residues in the active
site and in the A-C and J-K surrounding loops, which could explain the high fidelity of ZS.
1. INTRODUCTION
Sesquiterpene cyclases (STC) catalyze more than 300 distinct
C15 carbon skeletons, giving origin to a variety of sesquiterpene
lactones, ketones, alcohols, and aldehydes, which are the main
constituents of plant essential oils, many used for flavor and
fragrant applications.1−3 STC are metal-dependent enzymes
that catalyze the conversion of the universal sesquiterpene
substrate (2E,6E)-FDP, which originates from isopentenyl
diphosphate and dimethylallyl diphosphate from the mevalonic
acid pathway that operates in the cellular cytosol.4 Their
structure includes the active class I terpenoid synthase fold,
which contains the conserved aspartate-rich motifs DDXXD
and DTE/NSE located in the α-helices.5 Plant STC also
contains an N-terminal domain resembling the class II
terpenoid synthase fold with no specific catalytic activity.1
The reaction mechanisms of plant STC initiate through the
binding of divalent metal ions, mostly Mg2+, to the conserved
aspartate-rich motifs, which in turn coordinate the binding of
the phosphate moiety (PPi) from FDP by hydrogen bonds.
6
Thereafter, the enzyme undergoes a conformational change in
which the surrounding loops seal the active site, creating a
hydrophobic environment that prevents solvent entry.7−9
Consequently, the substrate undergoes ionization; thus, PPi
is cleaved and a transoid-allylic carbocation (farnesyl cation) is
generated. At this point, the reaction can be quenched to
generate linear cisoid or transoid sesquiterpenes, such as (E)-β-
farnesene,10 or can undergo cyclizations by two pathways: (1)
farnesyl cation undergoes immediate 10,1-cyclization for
(E,E)-germacradienyl cation or 11,1-cyclization for (E,E)-
humulyl cation. (2) farnesyl cation undergoes isomerization,
leading to the cisoid nerolidyl cation, followed by further
cyclizations and generates distinct intermediates: bisabolyl
cation (1,6-cyclization), cycloheptanyl cation (1,7-cyclization),
(Z,E)-germacradienyl cation (1,10-cyclization), or (Z)-humul-
yl cation (1,11-cyclization).11 Further reactions comprise
carbocation rearrangements, hydride shifts, and cyclizations,
which finalize by deprotonation quenching; thus, the
Received: January 26, 2019
Accepted: March 1, 2019
Published: April 3, 2019
Article
http://pubs.acs.org/journal/acsodfCite This: ACS Omega 2019, 4, 6199−6209
© 2019 American Chemical Society 6199 DOI: 10.1021/acsomega.9b00242
ACS Omega 2019, 4, 6199−6209
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
D
ow
nl
oa
de
d 
vi
a 
LE
IB
N
IZ
 U
N
IV
ER
SI
TA
ET
 H
A
N
N
O
V
ER
 o
n 
A
pr
il 
15
, 2
01
9 
at
 1
0:
58
:5
8 
(U
TC
). 
Se
e 
ht
tp
s:/
/p
ub
s.a
cs
.o
rg
/sh
ar
in
gg
ui
de
lin
es
 fo
r o
pt
io
ns
 o
n 
ho
w
 to
 le
gi
tim
at
el
y 
sh
ar
e 
pu
bl
ish
ed
 a
rti
cl
es
. 
22 
possibilities for rearrangements are vast and lead to a particular
product spectrum.12
The active site of each STC is characterized by a specific
conformation of residues, especially aromatic residues, which
guide the reactions of the prenyl tail and determines the
product specificity.6,11 For this reason, some STC generate
multiple products and are considered promiscuous, such as γ-
humulene synthase, which produces more than 52 products.13
Nevertheless, most STC generate few products and therefore
are considered high-fidelity enzymes, as shown by tobacco 5-
epi-aristolochene synthase (TEAS) that generates epi-aristo-
lochene, the precursor for the plant defense compound
capsidiol.8 Most STC are promiscuous in catalyzing alternative
substrates, accepting isoprene diphosphate substrates and
isoprenoid isomers.6 Acceptance for monoterpene substrates,
such as the ubiquitous geranyl diphosphate (GPP), has been
reported elsewhere.14,15 Moreover, acceptance of both GPP
and cisoid neryl diphosphate (NPP) has been demonstrated by
the patchoulol synthase.16 STC are also prone to accept
isomers from the sesquiterpene substrate (2E,6E)-FDP,
whereas catalyzation of isomers (2Z,6Z)-FDP,17 (2Z,6E)-
FDP,18 and (ZE,6Z)-FDP16 has been reported.
Of particular interest is the sesquiterpene khusimol,
contained in the vetiver essential oil from the tropical grass
Ch. zizanioides and used in nearly 20% of men’s perfumes due
to its woody smell.19 Further research has focused on its
medicinal properties and has reported antioxidant,20 anti-
microbial,21 and anti-inflammatory activity.22 Together with α-
and β-vetivone, khusimol is one of its main constituents and its
industrial extraction is performed by steam distillation from
dried roots.23
Despite its importance, there are few studies concerning the
biosynthesis of khusimol, which is most relevant to the
development of a biotechnological process. Previously, our
group described the heterologous expression in Escherichia coli
of ZS from Ch. zizanioides, which is the key enzyme in the
biosynthesis of khusimol.24 ZS was expressed fused with the
SUMO domain in the N-terminal section to improve solubility,
yielding a 64 kDa enzyme. ZS catalytical functionality was
demonstrated by the cyclization of (2E,6E)-FDP, which
generated the three-cyclic sesquiterpene (+)-zizaene (syn.
khusimene), the precursor for khusimol. However, further
knowledge is still required to understand the complex
enzymatic mechanisms of ZS. Hereby, we report for the first
time to our knowledge the product spectrum and reaction
mechanisms involved in ZS with the ubiquitous substrate
(2E,6E)-FDP and the alternative substrates NPP, GPP,
(2E,6Z)-FDP, and (2Z,6E)-FDP. Furthermore, dependence
on pH and temperature for product specificity was assessed by
altering the reaction conditions. Moreover, we analyze the
conformational changes during catalysis and the identification
of putative key residues that take part in the catalytical process.
The generated knowledge provides the basis for understanding
the reaction mechanisms of ZS for further protein engineering
studies.
2. RESULTS AND DISCUSSION
2.1. Biotransformation Assays and Product Identi-
fication of ZS with (2E,6E)-FDP. The product spectrum of
the reaction of ZS with the naturally occurring substrate
(2E,6E)-FDP was assessed by biotransformation assays based
on the single-vial method reported by O’Maille et al.25 Similar
to our previous report,24 the main product of the reaction was
sesquiterpene (+)-zizaene (91.46% abundance). Additionally,
we identified β-acoradiene (8.54% abundance) as a side
product (Figure 1), which is found in traces in the vetiver
essential oil19 and is a deprotonated compound from the
acorenyl cation, an intermediate in the biosynthesis of
(+)-zizaene.26
2.2. Optimization of Reaction Conditions. The optimal
temperature and pH of the reaction of ZS with (2E,6E)-FDP
was determined for the main product (+)-zizaene; thus, the
optimal region for the reaction rate (>1.6 μM min−1) was
calculated between pH 7.33−7.65 and temperature 34.15−
38.10 °C (Figure 2a). The medium reaction rate (1.4−1.6 μM
min−1) was determined between pH 7.0−7.8 and 32.5−42.0
°C of temperature. Consequently, optimal reaction conditions
were defined at pH 7.5 and 36 °C for further tests. The activity
of STC takes place in cytosol,29 which is characterized by pH
7.5.30 Therefore, optimal pH of ZS was found within the
expected range and was similar to that for other reported
STC.31−33 Activity of ZS was detected even between 21 and 42
°C at pH 7.0. Consequently, the broad temperature range for
ZS activity allows the vetiver grass to produce (+)-zizaene
under different climates.34
2.3. Analysis of Kinetic Parameters. A study for the ZS
kinetic parameters was carried out under the determined
optimal reaction conditions (36 °C, pH 7.5) with 0.1 μM
purified ZS and monitored in a range of 1−50 μM (2E,6E)-
FDP. Respective velocities were calculated by the product
formation only for the main product: (+)-zizaene. Figure 2b
describes the kinetics of ZS, where velocities increased from 1
to 5 μM of (2E,6E)-FDP with Vmax 0.35 μM min
−1, KM 0.88
μM, and kcat/KM 6.71 × 10
4 M−1 s−1. Consequently, the
catalytic efficiency of ZS was higher under optimal conditions
when compared with our previous report,24 which achieved
Vmax 0.32 μM min
−1, KM 1.11 μM, and kcat/KM 4.43 × 10
4 M−1
Figure 1. (A) Product spectrum of the biotransformation assay of
(2E,6E)-FDP with ZS by gas chromatography-mass spectroscopy
(GC-MS). (+)-Zizaene: (B) mass spectrum from peak 1. (C) Mass
spectrum of authentic (+)-zizaene from vetiver oil. (D) Mass
spectrum of authentic (+)-zizaene from ref 27. β-Acoradiene: (E)
mass spectrum from peak 1. (F) mass spectrum of authentic β-
acoradiene from vetiver oil. (G) Mass spectrum of authentic β-
acoradiene from ref 28.
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s−1. The difference between both studies was the increase in
temperature to 36 °C, which favored reaction rates and
lowered KM. The low values of the obtained kinetic parameters
were expected for plant enzymes from the secondary
metabolism, because their products are not required for
essential metabolic functions.30 Consequently, our results are
in accordance with similar reported STC activities.35−38
In our previous report, ZS followed an apparent Michaelis−
Menten kinetics,24 although a slight decrease in velocity was
observed from 30 to 40 μM (2E,6E)-FDP. In optimal reaction
conditions, ZS showed a decrease in velocities from 10 to 50
μM (2E,6E)-FDP (velocities of 0.29−0.15 μM min−1).
Consequently, ZS kinetics follows a substrate inhibition
model when the reaction is held at optimal conditions. Such
kinetics were also reported for the recombinant patchoulol
synthase39 and ent-Copalyl diphosphate synthase (diterpene
cyclase). Apparently, an excess of substrate binds to two
different sites in the enzyme: the substrate binding site
(aspartate-rich motif) and the active site,40 forming non-
productive binding (ESS). Moreover, the above-mentioned
study demonstrated that the cofactor (Mg2+) served also as an
inhibitor at levels higher than 0.1 μMMgCl2. In the case of ZS,
Figure 2. (A) Optimization of temperature and pH in the biotransformation of (2E,6E)-FDP with ZS. Variable of study corresponds to the
reaction rate of zizaene. (B) Enzyme kinetics plot of ZS showing reaction velocities at increasing concentrations of (2E,6E)-FDP. Reaction
velocities calculated from five measurements by a discontinuous assay method and performed in triplicates. Error bars represent standard deviation
(SD) of three independent measurements.
Figure 3. GC-MS analysis of the product spectrum of the reaction of ZS with alternative substrates. Monoterpene substrates: (A) GPP. (B) NPP.
Sesquiterpene isomer substrates: (C) (2Z,6E)-FDP. (D) (2E,6Z)-FDP. Mass spectra for each product can be found in Tables S1 and S2.
Table 1. Identification of the Product Spectrum Obtained from the Biotransformation of Monoterpene Substrates (GPP and
NPP) with ZS
abundance (%) RI samples
peak compound GPP NPP GPP NPP RI literature identificationa references
3 β-myrcene 40.32 26.93 1151 1151 1155 (a)(b) 43
4 limonene 4.2 12.68 1182 1182 1180 (a)(b) 44
5 sabinene 1.45 3.72 1185 1185 1156 (a)(b) 45
6 terpinolene 1.71 3.73 1266 1266 1266 (a)(b) 46
7 trans-sabinene hydrate 1.12 3.28 1440 1440 1447 (a)(b) 47
8 β-linalool 8.21 7.28 1524 1524 1531 (a)(b) 48
9 α-terpineol 23.87 29.63 1669 1669 1669 (a)(b)(c) 49
10 trans-geraniol 19.12 1817 1822 (a)(b) 50
11 cis-geraniol 12.75 1772 1777 (a)(b) 50
aIdentification of compounds: (a) Mass spectrum from the sample matches the library mass spectrum. (b) Retention index of sample matches the
retention index in the literature. (c) Mass spectrum and the retention index of the sample matches the authentic standard; both run in the same
GC-MS system. Mass spectrum of samples can be found in Supporting Information (SI), Table 1.
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amounts higher than 10 mM MgCl2 proved also inhibition.
Consequently, substrate inhibition plays a role in the
regulation of terpene metabolism; hence, the levels of cofactors
(divalent metal ions) are modulated by physical factors, such as
light.40 Further studies are required to clarify whether physical
factors or nutrient uptake regulate the levels of cofactors and
khusimol biosynthesis in roots of Ch. zizanioides.
2.4. Reaction Mechanisms of ZS with C10 Substrates.
To analyze the enzymatic versatility of ZS, the alternative
substrates C10, C15, and C20 prenyl diphosphates were
Scheme 1. Proposed Reaction Mechanisms of ZS with Distinct C10 and C15 Substrates
a
a(A) Reaction mechanism for monoterpene substrates GPP and NPP. Colors indicate unique products according to the substrate. The mechanism
is modified from Alonso and Croteau.15 (B) Reaction mechanism from sesquiterpene substrate isomers (2E,6Z)-FDP and (2Z,6E)-FDP. (C)
Reaction mechanism from the naturally occurring sesquiterpene substrate (2E,6E)-FDP. Final products are highlighted in gray. Mechanisms are
modified from Mercke et al.32 and Aaron et al.7
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evaluated (Figure 3). ZS accepted both monoterpene
precursors (NPP and GPP) and produced a mixture of cyclic
and acyclic monoterpenes (Table 1). Product formation was
catalyzed due to the activity of ZS; hence, no products were
observed in negative controls (reactions with alternative
substrates without ZS). Accordingly, ZS was able to accept
monoterpene substrates due to the large active cavity
compared to that of the short C10 prenyl tail, as demonstrated
by other STCs.32,41,42
As shown in the proposed reaction mechanisms for
monoterpene substrates (Scheme 1a), GPP undergoes
ionization to geranyl cation (2). On one side, it hydroxylates
to trans-geraniol (3) and on the other, isomerizes to linalyl
diphosphate (4) for further ionization to form linalyl/neryl
cation (6). In contrast, NPP leads directly to neryl cation (6)
after ionization and leads further to cis-geraniol (syn. Nerol)
(8). As a result, both substrates converge into linalyl/neryl
cation, leading to three paths: (1) deprotonation to the acyclic
β-mycerene (7), (2) hydroxylation to β-linalool (9), and (3)
6,1-cyclization to α-terpinyl cation (10), the precursor of cyclic
monoterpenes. Further, both follow quenching by deprotona-
tion to yield limonene (11) and terpinolene (12), water
addition for α-terpineol (13), and 2,6-ring closure to thujyl
cation (15). Finally, sabinene (16) and trans-sabinene-hydrate
(17) are formed.
As a consequence, product specificity of both substrates was
low, generating eight monoterpenoids. GPP and NPP yielded
as major products β-mycerene (40.3%, 26.9%) and α-terpineol
(23.8%, 29.6%), respectively, and geraniol isomers (GPP:
trans-geraniol 19.1% NPP: cis-geraniol 12.7%). Interestingly,
both substrates converted more than 50% to hydroxylated
monoterpenes (α-terpineol, β-linalool, trans-sabinene hydrate,
trans-geraniol, and cis-geraniol). Possibly, water molecules
surrounding the active site of ZS are activated and assist the
hydroxylation process. Such hydroxylation was demonstrated
before, wherein a water molecule found in the active site of
salvia monoterpene synthase participated in the water addition
of α-terpinyl cation to generate α-terpineol.53
2.5. Reaction Mechanisms of ZS with C15 and C20
Substrates. Assays with FDP isomers converted only to
nonhydroxylated sesquiterpenes (Table 2), whereas geranyl-
geranyl diphosphate did not produce any products. It is known
that STC do not accept C20 prenyl diphosphates substrates
because the prenyl tail is too large to fit in the cavity of
STC.17,54
The proposed reaction mechanism for isomer (2E,6Z)-FDP
leads to (2E,6Z)-farnesyl cation (19) after ionization and
further premature quenching to form (Z)-β-farnesene (20)
(Scheme 1b). Therefore, isomerization to nerolidyl diphos-
phate is not possible due to the (2E,6Z) stereochemistry of the
prenyl tail. Possibly, the prenyl tail does not position correctly
into the inner cavity of the active site and cannot undergo
further rearrangements. Consequently, (2E,6Z)-FDP reaction
resembles the functioning of farnesene synthases55,56 and
showed the highest product specificity with 100% abundance
of the main product in relation to all substrates tested.
Regarding (2Z,6E)-FDP, the proposed mechanism leads
directly to (2Z,6E)-farnesyl cation (22), after ionization of PPi
(Scheme 1b). One path leads to (E)-β-farnesene (23) (5.51%
abundance) and most of the flux leads to nerolidyl cation (24)
and further 6,1 ring closure to bisabolyl cation (25). After a
hydride shift, a 10,6-cyclization leads to acorenyl cation (27).
From here, two paths occur: one leads to β-acoradiene (26)
(12.79% abundance) by deprotonation and the other leads to
3,11-cyclization to form a three ring carbocationic intermediate
(29). The latter passes through a carbocation cascade with
final deprotonation to the main product (+)-zizaene (32).
Consequently, (2Z,6E)-FDP shows a high product specificity
for (+)-zizaene with an abundance of 81.7%. Additionally, the
low abundance of (E)-β-farnesene suggests a premature exit of
Table 2. Identification of the Product Spectrum Obtained from the Biotransformation of Sesquiterpene Substrates with ZS
alternative substrate peak compound compoundabundance (%) retention index identificationa references
sample literature
(2E,6Z)-FDP 13 β-(Z)-farnesene 100 1621 1630 (a)(b) 51
(2Z,6E)-FDP 1 (+)-zizaene 81.7 1617 1620 (a)(b)(c) 27
12 β-(E)-farnesene 5.51 1651 1659 (a)(b) 52
2 β-acoradiene 12.79 1670 1672 (a)(b)(c) 28
aIdentification of compounds: (a) Mass spectrum from the sample matches the library mass spectrum. (b) Retention index of sample matches the
retention index in the literature. (c) Mass spectrum and the retention index of the sample match those of terpene from the vetiver oil; both run in
the same GC-MS system. The mass spectrum of samples can be found in SI, Table 2.
Figure 4. Structural homology models of the open and closed conformations of the ZS active site docked with (2E,6E)-FDP. (A) Open
conformation of ZS shows the J-K and A-C loops in orange and Mg2+ divalent ions in green. (B) Closed conformation of ZS shows folding of the J-
K and A-C loops in red. Putative relevant residues for capping the active site are labeled.
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the (2Z,6E)-farnesyl cation from the active site for further
carbocation deprotonation.
2.6. Conformational Changes During Catalysis.
Analysis of docking models in open and closed conformations
shows the structural changes occurring during substrate
binding. Most relevant is the closing of the J-K and A-C
loops, wherein in the open conformation, they remain
unfolded, allowing the entrance of molecules (Figure 4a). In
the closed conformation, they fold to the active site (Figure
4b), acting as a lock to create a hydrophobic environment
suitable for carbocation cascades. Residue D651 from the J-K
loop is directed toward the binding site and possibly
participates in the coordination of divalent Mg2+ ions.
Additionally, Y653 folds toward the prenyl tail and is involved
in its stabilization. Contrary to Y653, Y647 does not suffer
major positioning because it is already near to the active site.
Subsequently, the R390 from the A-C loop folds toward the
PPi, completing the capping of the active site.
According to the docking model in the closed conformation,
MgA
2+ and MgC
2+ ions bind to the D427DIYD431 motif, and
MgB
2+ ion, to the ND572IASHE577 motif (Figure 5). Divalent
ions coordinate the metal binding of PPi from (2E,6E)-FDP
accompanied by hydrogen bond interactions, and water
molecules occupy the surrounding area, binding to the Mg2+
ions. Furthermore, the prenyl tail is located in the interior of
the active site (Figure 6a), surrounded by V423 and D651
residues and the aromatic residues Y647, Y653, W399, and
F420, which in turn, stabilize the complex in the closed active
site conformation.
2.7. Reaction Mechanism of ZS with (2E,6E)-FDP. The
proposed reaction mechanism undergoes ionization of
(2E,6E)-FDP, whereas the PPi group is cleaved and the
(2E,6E)-farnesyl cation is formed (Figure 6b). The D651
assists the FDP isomerization by sequestering the farnesyl
cation (34) at C1, which in turn captures further the PPi
moiety, leading to nerolidyl diphosphate (35) (Scheme 1c).
Likewise, the positively charged residues R390 and R568
sequester the PPi anion and pull it apart from the prenyl tail, as
reported by Bohlmann et al.6 After ionization of the
diphosphate isomer, nerolidyl cation (4) is formed and V423
together with Y653 assists the positioning of the carbocation
inside the inner cavity.
Furthermore, C1 bends toward C6, promoting the 6,1-
cyclization, leading to the bisabolyl cation (25). The C6
positive charge could be stabilized either by Y653 or W399
through π−cation interactions, and after an alkyl shift, the
homobisabolyl cation (26) is formed. Further cyclizations and
rearrangements could be concerted by aromatic residues
positioned in the interior of the cavity (F639, W399, and
F420), as shown in Figure 6b. Thereafter, electrophilic attack
of C10 of homobisabolyl cation leads to the 10,6-cyclization to
form the double-ring acorenyl cation (27), which branches
into two paths: deprotonation to form β-acoradiene (28) and
3,11 ring closure that leads to a triple ring intermediate (29).
Further carbocation rearrangements include an alkyl shift (30),
methyl shift (31), and deprotonation to form the main product
(+)-zizaene (32). Eventually, W399 functions as a proton
acceptor in the final deprotonation reaction.8
The latter reaction mechanism follows a related biogenic
origin for sesquiterpenes derived from the bisabolyl cation, a
primary intermediate for diverse sesquiterpene families:
bisabolene, curcumene, β-acoradiene, zizaene, cedrene, dupre-
zianene, and sesquithuriferol.26 ZS is able to undergo
successfully the 10,6-ring closure that leads to acorenyl cation.
Nevertheless, the complex 3,11-cyclization is not fully
processed; thus, the side product β-acoradiene is formed.
Although the 2,11-cyclization could be another favorable path,
Figure 5. Docking model showing the interactions that occur during
binding of (2E,6E)-FDP in the active site of ZS. Metal coordination
interactions are shown between D572, E579, D427, and D431
residues (red) from the aspartate-rich motifs with the Mg2+ divalent
ions (light green) and water molecules (red spheres). Putative
hydrogen bond interactions shown between R390 and R568 (light
gray) with the phosphate moiety of FDP (blue/orange).
Figure 6. Proposed interacting residues of ZS with (2E,6E)-FDP (A) and (2E,6E)-farnesyl cation (B) during binding and isomerization of FDP
based on docking modeling. Putative interacting residues from helices are marked in red, and residues from J-K loop are marked in light gray.
Phosphate moiety of FDP is shown in blue/orange, prenyl tail/farnesyl cation in dark green, and Mg2+ divalent ions in light green.
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it seems at this point that ZS is prone to early quenching and
deprotonation occurs. However, most of the flux successfully
undergoes 3,11-cyclization and, after different rearrangements,
(+)-zizaene is formed with a 91.46% abundance, resulting in
high product specificity.
It is known that aromatic residues in the active site are able
to stabilize the partial positive charges of carbocation
intermediates either by charge−quadrupole or cation−π
interactions.1 Accordingly, plant STC comprise conserved
aromatic residues in the active cavity,8 such as Y647, Y653, and
W399, found in both ZS and TEAS. Interestingly, ZS includes
two additional aromatic residues (F420 and F639), which are
crucial for the stabilization of the complex carbocations and
cyclizations in the biosynthesis of (+)-zizaene. Additionally,
the active cavity volume of ZS was calculated in 367.7 Å3,
which could be considered tight when compared with other
STC cavity volumes that are over 415 Å3.57,58 This suggests
that the ZS cavity does not have enough space to allow
alternative conformations of the prenyl tail, which results in an
almost unique reaction pathway and high product specificity.
2.8. Effect of Temperature and pH on Product
Specificity. The complex mechanisms of STC are affected
by reaction conditions, such as pH and temperature, which
regulate the product ratio (proportion of generated terpe-
noids), as demonstrated by others.12,18 To evaluate the pH and
temperature effect on product specificity, an analysis was
conducted on the product spectrum of ZS with the substrate
(2E,6E)-FDP by the single-vial method assay.25 Accordingly,
the temperature was evaluated from 21 to 42 °C at pH 7.5 and
pH was tested from pH 6.5 to 8.5 at 36 °C. In the case of
temperature, a minor decrease in the product ratio for the main
product (+)-zizaene was observed at increasing temperatures
(Figure 7); hence, it shifted from 92.73 to 89.6% in
temperatures from 21 to 42 °C. On the contrary, the side
product β-acoradiene showed an increase from 7.27 to 10.4%
at increasing temperatures (21−42 °C).
It has been demonstrated previously that temperature has an
effect on product specificity for other STCs;16,18 thus, 5-epi-
aristolochene synthase (TEAS) showed a trend in which
higher temperatures decreased the production of the main
product from 87.6 to 66.2% (21.4% shift). It was proposed that
higher temperatures increased the protein motion and
destabilized the J-K loop, allowing the exit of intermediates
from the active site prior to cyclization.18 On the contrary, the
slight shift observed in the product ratio of ZS (3.13%)
suggests a strong global conformation of the enzyme to endure
energetic fluctuations. Moreover, it suggests an efficient
binding of the J-K and A-C loops to the binding site, which
seals the active site from external solvents, creating a
hydrophobic environment. According to our model (Figure
4), distinct residues from the surrounding loops could be
responsible for the binding efficiency, as they change their
position drastically from an open to a closed conformation.
The D651 residue from the J-K loop points to be critical in
binding efficiency, as it is positioned strategically in the closed
conformation and possibly participates in Mg2+ coordination
and farnesyl cation capture during FDP isomerization. In
addition, aromatic residues Y647 and Y653 seem also relevant
because they are able to bind and stabilize the prenyl tail.
Concerning pH experiments, it could be shown that pH had
less effect than temperature on the product ratio (Figure 7),
since (+)-zizaene levels decreased slightly from 90.75 to
89.88% in the studied pH range (6.5−8.5). Similar to
temperature, the alternative product β-acoradiene tends to
increase its product ratio from 9.25 to 10.12% at higher pH
values. Distinct STCs have shown product ratio dependence
on pH12,16,59 because it affects the reaction solvent and, in
turn, distinct reactions such as hydride shifts, deprotonations,
and hydroxylations. A relevant mechanism for pH dependence
was proposed for the fungal STC Cop4 from Coprinus cinereus,
where basic residues (histidines) in the H-1α loop showed
susceptibility to pH changes due to net charge shifts.60 As a
result, this decreased the binding efficiency of the H-1α loop to
the binding pocket, allowing early quenching. In the case of ZS,
t h e H -1α l o op (L 4 9 4 IDAAKCY 5 0 1 ) , J -K l oop
(Y647NGVDLYTI655), and A-C loop (L386TFARDR392) are
composed mostly of hydrophobic and neutral residues.
Because of their polarity, they remain unaffected at the tested
pH and are able to seal efficiently the binding pocket, creating
a hermetic hydrophobic cavity.
3. CONCLUDING REMARKS
The described work leads to new insights into the character-
istics, product spectrum, and reaction mechanisms of the
recombinant ZS. A deeper study of the enzyme kinetics reveals
that ZS follows a substrate inhibition model that has been
observed in other terpene cyclases as a putative regulation
mechanism for the biosynthesis of terpenoids.
Furthermore, analysis with alternative substrates shows low
product specificity of ZS when assayed with C10 substrates but
high product specificity when converting C15 isoprenoid
diphosphate substrates. The proposed reaction mechanisms
reveal critical carbocations and cyclizations through the
Figure 7. Study of the dependency of temperature and pH to the product ratio of (+)-zizaene (■) and β-acoradiene (●) in cyclization assays of
(2E,6E)-FDP with ZS. Error bars represent the SD of three independent measurements.
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biosynthesis of the generated terpenoids. Moreover, the
conformational changes during catalysis were analyzed and
putative residues were identified involved in the efficient
capping of the active site. Our results provide new insights into
the complex reaction mechanisms of ZS, pointing to further
studies that require an interdisciplinary approach concerning
molecular biology, enzymology, and protein engineering.
4. MATERIALS AND METHODS
4.1. Chemicals. Monoterpene substrates GPP, NPP,
sesquiterpene substrate (2E,6E)-FDP, terpene standards, and
additional chemicals were purchased from Sigma-Aldrich. FDP
isomers (2E,6Z)-FDP and (2Z,6E)-FDP were chemically
synthesized according to Frister.39 Vetiver oil from Haiti was
kindly provided by Symrise.
4.2. Strain and Cultivation. Expression vector harboring
the recombinant fused SUMO zizaene synthase gene used for
enzyme production corresponds to the pETSUMO::ZIZ(co)
(GenBank: KP231534) and was transformed into E. coli strain
Bl21 (DE3) from Novagen, as described in Hartwig.39
Cultivation was carried out in a 2 L stirred-tank bioreactor
(Biostat-B Sartorius, Germany) with 2 L of defined medium61
supplemented with 20% glucose as the sole carbon source and
50 μg mL−1 kanamycin. Inoculation was performed to obtain
an initial OD600 of 0.1 rel. AU and the bioreactor controller
was set to 37 °C, pH 7.5 and controlled with 1 M NaOH,
initial stirring at 300 rpm, and air gassing at 0.5 vvm. The
dissolved oxygen (pO2) was monitored by a polygraphic pO2
sensor, set above 30% saturation, and controlled in cascade
mode with the following settings: (1) stirring and (2) pure
oxygen gassing. Induction of ZS was initiated when the culture
reached OD600 0.7 rel. AU. Thereafter, the temperature was
lowered to 20 °C and 0.5 mM isopropyl-β-D-thiogalactoside
was added. The induction stage was carried out for 24 h,
thereafter the culture broth was centrifuged for 20 min (10000
× g at 4 °C) and the pellet was stored at −20 °C until further
use.
4.3. Enzyme Purification. Cells were resuspended at a
concentration of 50 mg of fresh weight per mL with binding
buffer (50 mM 3-(N-morpholino) propane sulphonic acid
(MOPS), pH 7.5, 150 mM NaCl, 10 mM MgCl2, 10 mM
imidazole) and then cell disrupted by ultrasonication
(Sartorius Labsonic, Germany) using the following parameters:
0.6 s cycle, 100% amplitude. After centrifugation, soluble
protein fractions were filtered through 0.2 μm polyethersulfone
syringe filters. Enzyme purification was carried out by
immobilized metal affinity chromatography (IMAC) through
an ÄKTA Pure FPLC system (GE Healthcare), whereas
clarified soluble fractions were applied to a HiPrep IMAC FF
16/10 20 mL column (GE Healthcare) decorated with Ni2+
ions. After a proper column wash, the enzyme was eluted with
elution buffer (50 mM MOPS, pH 7.5, 150 mM NaCl, 10 mM
MgCl2, 500 mM imidazole). Purified fractions were pooled
into a vivaspin 20 10-kDa cut ultrafiltration tubes and the
buffer was exchanged to STC storage buffer (50 mM MOPS,
pH 7.5, 1 mM dithiothreitol (DTT), 10 mM MgCl2, 10% (v/
v) glycerol) and stored at −20 °C.
4.4. Biotransformation Assay. The catalytical reaction
was performed following a modified single-vial assay method
from O’Maille et al.25 consisting of reactions of 1 mL with
activity buffer (50 mM MOPS, 1 mM DTT, 10 mM MgCl2,
10% (v/v) glycerol) at pH 7.5, 5 μM (2E,6E)-FDP, and 0.1
μM purified ZS. Reaction components were gently mixed in 8
mL glass vials and incubated at 30 °C in a water bath for 10
min. Reactions were stopped and products extracted by adding
250 μL of pentane and vigorously vortexed for 60 s. Vials were
centrifuged for 10 min (4400 × g, room temperature), and the
organic phase was transferred to 1.5 mL GC vials for further
measurements.
4.5. Gas Chromatography Analytics. Quantitative
measurements of terpene products were performed by gas
chromatography- flame ionization detector (GC-FID) with a
GC-2010 plus GC system (Shimadzu, Japan) coupled to a
flame ionization detector. Organic phase samples of 2 μL were
injected via an autosampler under a splitless mode (injector
temperature of 240 °C), and separation was carried out on a
Zebron ZB-Wax Plus column (30 m length, 0.25 mm i.d., 0.25
μm film thickness) (Phenomenex). The oven temperature
program was set to 40 °C for 20 s, then raised to 200 °C (10
°C min−1) and 0.5 min hold, and then raised to 230 °C (30 °C
min−1) and 2 min hold. The FID was heated to 300 °C. Due to
the lack of (+)-zizaene and β-acoradiene standards, quantifi-
cation was calculated with a calibration curve of α-cedrene
standard, which has an equivalent mass (204 m/z), as
demonstrated previously.24
Reaction products were identified by GC-MS with a 7890B
GC system (Agilent) coupled to an Agilent 5977A mass
selective detector and equipped with a VF-WAXms capillary
column (30 m × 0.25 mm i.d. × 0.25 μm) (J&W Scientific).
The transfer line and ion source temperature were set at 230
°C and the quadrupole at 150 °C. The ionization energy was
set at 70.0 eV, and the scan range, from 33 to 300 m/z.
Samples of 0.5 μL were injected into the device by the on-
column mode, using helium 5.0 as the carrier gas with a
constant gas flow of 1 mL min−1. The oven temperature
program was set to 40 °C for 3 min and then raised to 230 °C
(10 °C min−1) and a 10 min hold. Mass spectra data were
analyzed with MassHunter Qualitative Analysis 7.0 (Agilent)
and retention indices (RI) calculated according to van Den
Dool and Kratz62 by an alkane standard solution (C8−C30).
For product identification, mass spectra and RI of samples
were compared to those of others available in the mass spectral
database NIST 14, literature references, terpenes from the
vetiver oil of Ch. zizanioides, and/or authentic standards.
4.6. Optimization of the Reaction Conditions. The
reaction conditions of the biotransformation assay of (2E,6E)-
FDP with ZS were analyzed using a two-level factorial
experimental design with the reaction rate of (+)-zizaene as
the study variable. Analyzed factors included temperature and
pH, each at two levels (30 °C/pH 7, 42 °C/pH 7, 30 °C/pH 8,
and 42 °C/pH 8) and one central point (36 °C/pH 7.5).
Reactions for each treatment were carried out in 6 mL of
master reaction solutions of activity buffer (Section 2.4) with 5
μM (2E,6E)-FDP and 0.1 μM purified ZS in 8 mL glass vials.
Master solutions were aliquoted rapidly into five 1 mL
fractions in 8 mL glass vials and incubated in a water bath with
the corresponding temperature for 2, 4, 6, 8, and 10 min.
Immediately after incubation, 250 μL of iso-octane was
promptly added and the reaction was quenched and products
extracted by vigorous shaking. The organic phase was
transferred to GC vials after centrifugation, and products
were quantified by GC-FID. Each reaction condition was held
in triplicates, and the reaction rate (μM min−1) of (+)-zizaene
was calculated from the average slope, obtained by linear
regression.
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4.7. Enzyme Kinetics Parameters. Kinetical parameters
of ZS were determined using the optimal reaction conditions
(36 °C, pH 7.5) with increasing concentrations of the
ubiquitous substrate (2E,6E)-FDP (1−50 μM) and 0.1 μM
purified ZS. Reactions proceeded as shown in Section 2.6, with
the corresponding concentration of (2E,6E)-FDP and
(+)-zizaene quantified by GC-FID. Kinetic parameters were
calculated from the velocities, which corresponded to the
reaction rate (μM min−1) of the main product (+)-zizaene.
Data was fitted to the substrate inhibition model (eq 1),63
using the enzyme kinetics substrate inhibition module from
GraphPad Prism 7 software (GraphPad).
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4.8. Alternative Substrates. Product profiles of mono-
terpenes substrates GPP/NPP and sesquiterpene substrate
isomers (2E,6Z)-FDP and (2Z,6E)-FDP were determined by
biotransformation assays with ZS. Reactions were performed at
36 °C and pH 7.5 with 5 μM alternative substrate and 0.1 μM
purified ZS. Negative controls were carried out by reactions
with alternative substrates without ZS. Furthermore, reactions
were carried out according to the method described in Section
2.5. Identification of the generated products was performed by
GC-FID and GC-MS, as described in Section 2.6.
4.9. Temperature and pH Dependency in Product
Specificity. The product ratio of (+)-zizaene and β-
acoradiene was assessed through varying temperatures and
pH by the biotransformation assay with 5 μM (2E,6E)-FDP
and 0.1 μM purified ZS. Temperature dependence was studied
between 21 and 42 °C at pH 7.5, and pH dependency, in the
range of 6.5−8.5 pH at 36 °C. The biotransformation assay
was performed as explained in Section 2.6, and sesquiterpenes
were quantified by GC-FID. The product ratio was calculated
as the amount of (+)-zizaene or β-acoradiene divided by the
total amount of both.
4.10. Homology and Docking Modeling. Tridimen-
sional structures of ZS were modeled using as templates the
crystal structures of 5-epi-aristolochene synthase (TEAS) from
Nicotiana tabacum, reported by Starks et al.8 The ZS open
conformation model was built with the unliganded TEAS
structure (PDB 5EAS, chain A, 32.4% identity) and the closed
conformation with the TEAS structure liganded with 3 Mg2+
and FHP (PDB 5EAT, chain A, 31.9% identity). For
constructing the homology models, the SWISS-MODEL
homology-modeling tool64 was used together with the ZS
sequence (GenBank: KP231534) and the aforementioned
templates.
Furthermore, molecular dockings of (2E,6E)-FDP and
(2E,6E)-farnesyl cation with the ZS model in closed
conformation were carried out using the AutoDockTools
suite 1.5.6. (The Scripps Research Institute).65 For this,
preparation of the ZS receptor file involved the elimination of
water molecules, adding and merging of hydrogen atoms, and
adding Gasteiger charges. The grid was programmed as
follows: grid box (60 × 60 × 100) with default grid spacing
(0.375 Å) that covered the active site, map types set directly
including Mg2+ to the list, and a grid parameter file computed
by AutoGrid 4.0. Docking settings included 25 GA runs,
Lamarckian genetic algorithm for output, and AutoDock 4.065
used for the generation of the docking parameter file. Docking
conformations of both substrates presenting low binding
energy were selected, and metal interactions occurring in the
binding site were analyzed by the metal geometry tool from
UCSF Chimera 1.11.2 (University of California).66 The active-
site cavity volume of ZS was measured by the computer atlas of
surface topology of proteins (CASTp) version 3.0.67 Structural
model images were rendered by the program UCSF
Chimera.66
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4.2. Modulating the precursor and terpene synthase supply for the whole-cell biocatalytic 
production of the sesquiterpene (+)-zizaene in a pathway engineered E. coli 
Advances in synthetic biology have enabled the metabolic engineering of biosynthetic pathways 
from plant-based terpenes into microorganisms, usually engineered into E. coli or yeast as host 
systems. Specifically, the engineering of the MEV-pathway and the TPS, the critical enzyme for 
terpene biosynthesis, have contributed to the microbial production of fragrant terpenes. 
However, the efficient production of terpenes requires a balance in the supply of FDP and TPS. 
Therefore, chapter 2 tackles the optimization of the metabolic flux towards (+)-zizaene by 
optimizing the supply of FDP and the ZS, engineered in E. coli strains.  
As a first attempt for (+)-zizaene bio-production, the ZS gene was overexpressed in E. coli, using 
the FDP from the endogenous MEP-pathway from E. coli. Although the titers were low, the 
overexpression of soluble ZS protein amounts was high, suggesting a low supply of endogenous 
FDP.  
To improve the substrate supply, the exogenous MEV-pathway was engineered with the ZS gene 
cloned downstream from the operon in a poly-cistronic pMevZS vector, which augmented the 
(+)-zizaene titer by 2.7-fold when compared to the first attempt. Paradoxically, the soluble ZS 
protein amounts declined, suggesting that the limiting supply shifted to the ZS.  
As a solution, the cloning strategy changed towards multiple mono-cistronic plasmid strains and 
two promoters (T7 and PBAD) were tested. As expected, the multi-plasmid TZS+Mev strain with 
the strong T7 promoter improved the zizaene titer 7.2-fold more than the poly-cistronic MevZS 
strain. Moreover, SDS-PAGE gels confirmed a dramatic improvement in the overexpression of 
the soluble ZS protein amounts from the TZS+Mev strain.  
In an effort to further improve the (+)-zizaene titer, the ZS supply was increased by applying a 
technique used mostly for plant transformation, the overexpression of multi-gene copies. 
Therefore, the TZS+MevZS strain was constructed by cloning two copies of the ZS gene into two 
different plasmids, under the control of two different promoters (T7 and lacUV5). As a result, 
this strain improved the (+)-zizaene titer 1.3-fold more when compared to that of the one gene 
copy strain (TZS+Mev). These observations confirmed that the bottleneck with the one gene copy 
strain was still the ZS supply and that the metabolic flux between the substrate FDP and ZS 
achieved its maximum optimization level by overexpressing the ZS gene with two gene copies. 
After demonstrating the biotechnological production of (+)-zizaene, the optimization of the 
fermentation conditions was studied. For that, the culture media, pH, temperature and E. coli B 
strains were evaluated and the (+)-zizaene titers improved 2.2-fold, achieving a (+)-zizaene 
production of 25.09 mg L‒1. These results offer the basis for the development of the (+)-zizaene 
bioprocess and provide an alternative method for the metabolic engineering of terpenes.
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Abstract: The vetiver essential oil from Chrysopogon zizanioides contains fragrant sesquiterpenes
used widely in the formulation of nearly 20% of men’s cosmetics. The growing demand and
issues in the supply have raised interest in the microbial production of the sesquiterpene khusimol,
the main compound of the vetiver essential oil due to its woody smell. In this study, we engineered
the biosynthetic pathway for the production of (+)-zizaene, the immediate precursor of khusimol.
A systematic approach of metabolic engineering in Escherichia coli was applied to modulate the
critical bottlenecks of the metabolic flux towards (+)-zizaene. Initially, production of (+)-zizaene
was possible with the endogenous methylerythritol phosphate pathway and the codon-optimized
zizaene synthase (ZS). Raising the precursor E,E-farnesyl diphosphate supply through the mevalonate
pathway improved the (+)-zizaene titers 2.7-fold, although a limitation of the ZS supply was
observed. To increase the ZS supply, distinct promoters were tested for the expression of the ZS gene,
which augmented 7.2-fold in the (+)-zizaene titers. Final metabolic enhancement for the ZS supply by
using a multi-plasmid strain harboring multiple copies of the ZS gene improved the (+)-zizaene titers
1.3-fold. The optimization of the fermentation conditions increased the (+)-zizaene titers 2.2-fold,
achieving the highest (+)-zizaene titer of 25.09 mg L−1. This study provides an alternative strategy to
enhance the terpene synthase supply for the engineering of isoprenoids. Moreover, it demonstrates
the development of a novel microbial platform for the sustainable production of fragrant molecules
for the cosmetic industry.
Keywords: khusimene; (+)-zizaene; vetiver essential oil; khusimol; sesquiterpenes; microbial
production; metabolic engineering
1. Introduction
The cosmetic industry has extensively used essential oils for the formulation of perfumes due to
their complex mixture of fragrant hydrocarbons such as ketones, ethers, esters, alcohols, aldehydes,
and terpenoids [1]. From these natural products, terpenes such as volatilemonoterpenes, sesquiterpenes,
and diterpenes are the main constituents, which confer the specific odor to each essential oil [2].
Among the distinct essential oils, the vetiver essential oil (VEO) from the Ch. zizanioides
grass has drawn growing attention, because it is used in nearly 20% of men’s luxury perfumes [3].
Characterized by its dark woody smell, VEO holds a world production of 300–350 tons per year [4]
with prices ranging from $380–$500 per kg in 2018 [5] and expected growth in the market of $169.5
million for 2022 [6]. Industrial production of VEO is performed traditionally by steam distillation from
vetiver roots, harvested after 12–18 months of growth and at 1–2 m length; usually, this process attains
Genes 2019, 10, 478; doi:10.3390/genes10060478 www.mdpi.com/journal/genes
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an extraction yield of 0.2–3% and can be improved to 4% through supercritical fluid extraction [3,7].
The recurrent shortages in the supply of VEO from the main producer, Haiti due to rainfalls and
earthquakes [3,5], and the increasing market demand has raised the interest towards a reliable
biotechnological production of the main constituent of VEO, the sesquiterpene khusimol, which grants
the distinctive woody smell.
Similar to most plant sesquiterpenes, the biosynthesis of khusimol initiates from the glycolysis
cycle, which generates the precursors’ glyceraldehyde 3-phosphate (GAP) and pyruvate for the
plastidial methylerythritol phosphate (MEP) pathway, and acetyl coenzyme A (Acetyl-CoA) for the
cytoplasmic mevalonate (MEV) pathway [8]. Both pathways converge and catalyze the formation of
the terpene precursors isopentenyl pyrophosphate (IPP) and isomer dimethylallyl pyrophosphate
(DMAPP),which are further assembledby the farnesyl diphosphate synthase (IspA) to form theuniversal
sesquiterpene substrate E,E-farnesyl diphosphate (FDP) [9]. In the (+)-zizaene (syn. khusimene)
pathway, FDP is cyclized by the zizaene synthase (ZS) to yield (+)-zizaene and further hydroxylated to
khusimol by a specific P450 cytochrome monooxygenase [10].
The biosynthetic pathway of khusimol should be possible in E. coli because of the positive results
for the in vivo production of many sesquiterpenes [11]. Contrary to plants, E. coli produces endogenous
FDP exclusively by theMEP pathway and is vital for the biosynthesis of the intermediates undecaprenyl
diphosphate (UDP) and octaprenyl diphosphate (ODP) [12]. Accordingly, UDP is the direct precursor
of peptidoglycans, used for cell wall formation [13], and ODP is involved in the respiratory chain for
the biosynthesis of distinct quinones [14]. Consequently, amounts of FDP in E. coli are limited; thus,
efforts have been made to engineer the MEP pathway to enhance the supply of FDP. As an example,
the overexpression of the MEP pathway genes 1-Deoxy-D-xylulose 5-phosphate synthase (DXS) and
1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) increased the FDP levels and improved
the amounts of lycopene up to 22 mg L−1 [15]. Similarly, overexpression of the DXS synthase and
additionally, the isoprenyl diphosphate isomerase (Idi) with the farnesyl pyrophosphate synthase
(FPS) reached valerenadiene titers of 2.09 mg L−1 [12]. Although overexpression of the MEP pathway
improved the precursor supply, the terpene titers did not reach industrial levels, possibly due to control
mechanisms of E. coli or the formation of intermediates that limited the precursor supply [16,17].
As an alternative to raise the FDP supply, the heterologousMEV pathway was engineered in E. coli
by Keasling and co-workers for the in vivo production of amorpha-4,11-diene [17]. The heterologous
pathway involved the cloning of eight genes from E. coli and Saccharomyces cerevisiae into two operons:
MevT operon converted acetyl-CoA to mevalonate and MBIS operon catalyzed mevalonate to IPP and
DMAPP that led to FDP, yielding 112.2 mg L−1 as the highest amorpha-4,11-diene titer. The microbial
platform was further enhanced for the production of bisabolene by optimizing the codon usage to
E. coli for the S. cerevisiae genes and assembling the eight genes into one single operon under the control
of the lacUV5 (MevT genes) and trc promoter (MBIS genes) [18]. As a result, the upgraded platform
boosted the FDP supply and achieved titers of 900 mg L−1 of bisabolene.
The previously mentioned studies augmented the supply of the substrate FDP, which is further
catalyzed in the terpene pathway by a terpene synthase (TPS), performing complex reactions that
yield sesquiterpenes with precise structure and stereochemistry [19]. In the biosynthesis of khusimol,
the TPS is the ZS that catalyzes the cyclization of FDP to the tricyclic (+)-zizaene. Its enzymatic
characterization has been described by a recombinant codon-optimized variant fused to the small
ubiquitin-related modifier (SUMO), which increased the solubility of ZS and expressed heterologously
in E. coli [10]. Moreover, the catalytical specificity and enzymatic kinetics of the ZS enzyme have been
further characterized [20].
In this study, we report the metabolic engineering of (+)-zizaene biosynthesis in E. coli strains.
The engineering of the biosynthetic pathway involved the overexpression of the MEV pathway to
enhance the FDP supply, the evaluation of promoters to efficiently express the ZS, and the engineering
of multi-plasmid strains with multiple copies of ZS to boost the ZS supply. Moreover, optimization of
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the fermentation conditions and evaluation of E. coli strains were analyzed to improve the production
of (+)-zizaene.
2. Materials and Methods
2.1. Engineering of Vectors and Strains
The description of vectors and strains is summarized in Table 2. The pETSUMO::ZIZ(co) vector
was obtained from our previous study [10], and the sequence of the codon-optimized SUMO-fused
ZS gene was described in GenBank accession KP231534. The vector pBbA5c-MevT(CO)-MBIS (CO,
ispA), encoding the MEV pathway, was a gift from Jay Keasling & Taek Soon Lee (Addgene plasmid
#35151). The pJbei-6411 vector for the expression with the arabinose operon was a gift from Taek Soon
Lee (Addgene plasmid #47050).
The cloning procedures were carried out by the NEBuilder HiFi DNA Assembly method,
and PCR reactions were performed with the Q5 HiFi DNA polymerase, both following the provider
protocols (New England BioLabs, USA). Synthesis of oligonucleotides and sanger sequencing for clone
confirmation were performed by Microsynth Seqlab (Germany), and primer sequences are described
in Table 1.
Table 1. Primers used in this investigation.
Primers Description Reference
ZS-F-Mev catccagcgtaataaataagGATCTAGGAGGTAATGGGCAGCAGCCATCATC This study
ZS-R-Mev gagatccttactcgagtttgTCACACCGGAATCAGATTTACATAC This study
pJ6411-F-ZS cccaagattacgtacattg This study
pJ6411-R-ZS ttctttatcctcctagatcttttgaattcccaaaaaaacg This study
ZS-F-pJ6411 ccgtttttttgggaattcaaaagatctaggaggataaagaaATGGGCAGCAGCCATCATC This study
ZS-R-pJ6411 tcaatgtacgtaatcttgggTCACACCGGAATCAGATTTACATAC This study
Upper case sequences: Inserts. Lower case sequences: backbone vector. Upper case underlined sequences: IRES
For the production of (+)-zizaene by a single polycistronic vector, the ZS gene was cloned into the
pMev vector, directly after the IspA gene to yield the pMevZS vector. In brief, the ZS gene was amplified
from the pETZS vector by respective primers with complementary overhangs to the BamHI site of
the pMev vector. Additionally, an internal ribosome entry site (IRES) (GATCTAGGAGGTA) from the
MEV operon was cloned upstream from the ZS gene. Thereafter, the pMev vector was digested with
BamHI, assembled with the ZS gene and E. coli NEB 10-beta competent cloning strain (New England
BioLabs), which is specific for large vectors, was transformed with the pMev vector. For the testing of
the PBAD promoter through the pJbeiZS plasmid, the cytochrome P450 operon from pJbei-6411 vector
was removed, and the ZS gene from the pETZS vector was inserted instead. For that, both the insert
and backbone were amplified with complementary overhangs by PCR methods, seamlessly assembled,
and E. coli TOP10 competent cloning strains (IBA, Germany) were transformed for respective screening.
For the production of (+)-zizaene, E. coli expression strains were transformed or co-transformed
with the respective plasmids by common methods [21]. An exception was the BZS+Mev strain,
where the E. coli TOP10 competent cloning strain was used because expression with the arabinose
operon requires a non-metabolizing arabinose strain [22].
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Table 2. Strains and plasmids used in this investigation.
Plasmid Reference Plasmid Name
Description (Origin of Replication,
Promoter, Antibiotic Resistance
and Genes)
Reference
pETZS pETSUMO::ZIZ(co)
pBR322, PT7, Kan, harboring the
codon-optimized SUMO-fused ZS gene
from Ch. zizanioides
[10]
pMev pBbA5c-MevT(CO)-MBIS (CO, ispA)
p15A, PlacUV5, Cam, harboring the
mevalonate pathway genes: AtoB, HMGS,
tHMGR, MK, PMK, PMD, Idi and IspA*.
[18]
pJbei-6411 pJbei-6411
pBBR1, PBAD, Kan, harboring the arabinose
operon with the cytochrome P450
(CYP153A6) from Sphingomonas sp.
[23]
pMevZS
pBbA5c-MevT(CO)-MBIS (CO,
ispA)-SUMO::ZIZ(co)
p15A, PlacUV5, Cam, harboring the
mevalonate pathway genes* and the
codon-optimized SUMO-fused ZS gene
from Ch. zizanioides
This study
pJbeiZS pJbei-6411-SUMO::ZIZ(co)
pBBR1, PBAD, Kan, harboring the arabinose
operon and the codon-optimized
SUMO-fused ZS gene from Ch. zizanioides
This study
Strains Genotype/Description Reference
E. coli TOP10
F- mcrA (mrr-hsdRMS-mcrBC) φ80lacZ ∆M15 ∆lacX74 recA1 ara∆139 (ara-leu)7697 galU
galK rpsL (StrR) endA1 nupG
IBA
E. coli Bl21(DE3) F- ompT hsdSB (rB
-mB
-) gal dcm (DE3) Novagen
E. coli Tuner(DE3) F- ompT hsdSB (rB
-mB
-) gal dcm lacY1(DE3) Novagen
E. coli NEB 10-beta
∆(ara-leu) 7697 araD139 fhuA ∆lacX74 galK16 galE15 e14- φ80dlacZ∆M15 recA1 relA1
endA1 nupG rpsL (StrR) rph spoT1 ∆(mrr-hsdRMS-mcrBC)
NEB
E. coli SHuffle T7
fhuA2 lacZ::T7 gene1 (lon) ompT ahpC gal λatt::pNEB3-r1-cDsbC (SpecR, lacIq) ∆trxB
sulA11 R(mcr-73::miniTn10–TetS)2 (dcm) R(zgb-210::Tn10 –TetS) endA1 ∆gor
∆(mcrC-mrr)114::IS10
NEB
E. coli SHuffle T7 lysY
MiniF lysY (CamR)/fhuA2 lacZ::T7 gene1 (lon) ompT ahpC gal λatt::pNEB3-r1-cDsbC
(SpecR, lacIq) ∆trxB sulA11 R(mcr-73::miniTn10–TetS)2 (dcm) R(zgb-210::Tn10 –TetS)
endA1 ∆gor ∆(mcrC-mrr)114::IS10
NEB
Mev E. coli Bl21(DE3) harboring pMev This study
ZS E. coli Bl21(DE3) harboring pETZS This study
MevZS E. coli Bl21(DE3) harboring pMevZS This study
BZS+Mev E. coli TOP10 harboring pMev and pJbeiZS This study
TZS+Mev E. coli Bl21(DE3) harboring pMev and pETZS This study
TZS+MevZS E. coli Bl21(DE3) harboring pMevZS and pETZS This study
T-TZS+MevZS E. coli Tuner(DE3) harboring pMevZS and pETZS This study
SH-TZS+MevZS E. coli SHuffle T7 harboring pMevZS and pETZS This study
SHL-TZS+MevZS E. coli SHuffle T7 lysY harboring pMevZS and pETZS This study
Kan, kanamycin and Cam, chloramphenicol.
2.2. Evaluation of the Engineered Strains for the Production (+)-zizaene
Cultivations of E. coli were performed by inoculating 100 µL of respective strains from glycerol
stocks to 10 mL Lysogeny Broth (LB) pre-culture broths at 37 ◦C with respective antibiotics (kanamycin
at 30 µg L−1 and, or chloramphenicol at 34 µg L−1) until the stationary phase. Furthermore, production
cultures in sealed baffled shake-flasks with 35 mL of defined non-inducing broth (DNB) [24] were
inoculatedwith 2% (v/v) of seed culture andgrownat 37 ◦Cona rotatory shaker (150 rpm). After cultures
reached a cell density of OD600 0.6, (+)-zizaene production was induced by adding varying levels
(0.1, 0.5, and 1.0 mM) of isopropyl-β-D-1-thiogalactopyranoside (IPTG) and an overlay of 4 mL
iso-octane at 20 ◦C, (150 rpm) as a two-phase partitioning culture. After 24 h of induction, samples
were taken promptly for analytical measurements that included dried cell weight (DCW), cell density,
soluble ZS protein, and (+)-zizaene concentrations.
2.3. Optimization of the Fermentation Conditions for the Production (+)-zizaene
Cultivation and analytical procedures for media evaluation, optimization of growth temperature
and media pH, and testing of E. coli strains were carried out as described before with the best
performing strain. The evaluation of media comprised the defined media: defined non-inducing broth
(DNB), M9 minimal medium (M9) [25], and a modified Aparicio defined medium (ADM) with the
following composition (g L−1): (NH4)2SO4 10.0, NaCl 1.2, K2SO4 1.1, MgSO4·7H2O 0.15, K2HPO4
9.3, KH2PO4 2.03, CaCl2 0.01, FeSO4·7H2O 0.001, and CuSO4·5H2O 0.001 [26]. Defined media were
38 
Genes 2019, 10, 478 5 of 15
set to pH 7.2 and 5 g L−1 of glucose respectively. Additionally, the complex terrific broth (TB) [21]
was used as a control. The factorial design for the pH and temperature optimization consisted of
two factors with the following levels: pH (6.5, 7, and 7.5) and temperature (16, 20, 24, and 28 ◦C),
for a total of 12 combinations with three replicates. Data were analyzed and plotted using the Minitab
16 software (USA).
2.4. Analytical Measurements
2.4.1. ZS Protein Gel Electrophoresis Analysis
Production culture samples were normalized to an OD600 2, centrifuged for 10 min (10,000× g
at 4 ◦C) and free-media pellet was resuspended in 300 µL extraction buffer (50 mMMOPS, 150 mM
NaCl, 5 mM DTT, 10% (v/v) glycerol, pH 7.5). Cells were disrupted through an ultrasonicator
(Sartorius Labsonic, Goettingen, Germany) and soluble and insoluble protein fractions were separated
after 30 min centrifugation (10,000× g at 4 ◦C). Protein fraction samples were mixed with 2X loading
buffer, heated at 95 ◦C for 5 min and analyzed through a 10% sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE).
2.4.2. Identification and Measurement of (+)-zizaene by Gas Chromatography Analysis
Samples of 150 µL from the iso-octane overlay from production cultures were transferred to
GC-vials for gas chromatography analysis and product identification was carried out through GC-MS
using an Agilent 7890B system (Agilent, Santa Clara, CA, USA) with the following settings: sample
injections of 0.5 µL on-column mode through a 30 m VF-WAXms capillary column (0.25 mm internal
diameter I.D. × 0.25 µm, Agilent, USA); oven program of 40 ◦C for 3 min, increasing to 230 ◦C (10 ◦C
min−1) and final hold of 10min; helium 5.0 carrier gas at a constant gas flow of 1mLmin−1; temperature
of 230 ◦C for ion source, and 150 ◦C for quadrupole; mass scan range of 33–300 m/z and ionization
energy to 70 eV. Terpene products were identified by comparison of retention indices [27] and mass
spectra of samples with authentic standards from the VEO and references from the mass spectral NIST
14 database.
Quantification of (+)-zizaene was performed by GC-FID with a GC-2010 plus GC system coupled
to a flame ionization detector (Shimadzu, Japan) equipped with a 30 m Zebron ZB-Wax Plus column
(0.25 mm I.D. × 0.25 µm, Phenomenex, USA). Samples of 1 µL were injected under a splitless mode
with an injector temperature of 240 ◦C. The initial oven temperature was set to 40 ◦C for 20 s, ramped at
10 ◦C min−1 to 200 ◦C, held for 0.5 min, increased at a rate of 30 ◦C min−1 to 230 ◦C, and held finally
for 2 min. Because the (+)-zizaene standard is not commercially available, an α-cedrene standard was
used as an equivalent standard due to the relative abundance of the main peaks from the mass spectra
as described in our previous report [20].
3. Results
3.1. Engineering the Production of (+)-zizaene by the MEP Pathway
In this study, we engineered the biosynthetic pathway in E. coli for the production of (+)-zizaene,
using glucose as the sole carbon source (Figure 1). The key enzyme of the biosynthesis of (+)-zizaene
is the ZS, which catalyzes the cyclization of the substrate FDP to (+)-zizaene. Due to the plant
origin of TPS, most are expressed poorly in E. coli, leading to the formation of insoluble proteins
(inclusion bodies) [28,29]. To improve TPS solubility, a recombinant ZS variant was used, which was
codon-optimized for E. coli and fused with the SUMOmoiety from our previous work [30].
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Figure 1. Biosynthetic pathway engineered for the production of (+)-zizaene in E. coli by the expression
of the native methylerythritol phosphate (MEP) pathway, the heterologous MEV pathway and the
(+)-zizaene pathway. Heterologous expressed enzymes highlighted in blue. The MEP pathway
comprise the following enzymes: 1-Deoxy-D-xylulose 5-phosphate synthase (Dxs), 1-deoxy-D-xylulose
5-phosphate reductoisomerase (Dxr), MEP cytidyl transferase (MCT), cytidyl MEP kinase (CMK),
MEP-2,4-cyclodiphosphate synthase (MDS), (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase
(HDS), and (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (HDR). The MEV heterologous
pathway consisted of the following enzymes: acetyl-CoA acetyltransferase (AtoB), HMG-CoA synthase
(HMGS), truncated HMG-CoA reductase (tHMGR), mevalonate kinase (MK), phosphomevalonate
kinase (PMK), mevalonate diphosphate decarboxylase (PMD), and isoprenyl diphosphate isomerase
(Idi). The (+)-zizaene pathway comprises the farnesyl diphosphate synthase (IspA) and the zizaene
synthase (ZS).
For the overexpression of (+)-zizaene, the production cultures were performed by the two-phase
partitioning method [31] with a DNB medium and an overlay of iso-octane, which reduces the loss of
(+)-zizaene due to its volatility. After 24 h of culture, organic phases from production cultures were
obtained and analyzed through GC-MS for the identification of terpenes. All tested strains produced
(+)-zizaene as the main product (90%) and β-acoradiene as a side product (10%) (Figure 2), except for
theMev strain (negative control) because it lacks the ZS gene and harbors theMEV pathway (Figure 3a).
Additionally, the Mev strain produced farnesol, which is a product from the hydroxylation of FDP by
endogenous phosphatases from E. coli [32].
Figure 2. Identification of terpene products by GC–MS. (A) Total ion chromatogram. (B) Chemical
structures of the identified products. (C) Mass spectra of (+)-zizaene from the sample of the ZS+MevZS
strain. (D) Mass spectra of (+)-zizaene authentic standard from the vetiver essential oil. Comparison of
mass spectra for β-acoradiene is shown in the Supplementary Table S1.
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Figure 3. Comparison of the performance of the engineered E. coli BL21(DE3) strains induced at
different IPTG levels. (A) (+)-zizaene titers. (B) (+)-zizaene yields. (C) biomass from cell dry weight
(D) cell density. Data are the mean of four independent replicates from production cultures after 24 h
of induction with DNB medium, and the error bars represent the standard deviation. * BZS+Mev E. coli
Top10 strain induced with 1 mM IPTG and different levels of arabinose (Ara).
As a first attempt to produce (+)-zizaene, the TZS strain was constructed with the ZS gene under
the control of the T7 promoter and the FDP supply originated from the endogenous MEP pathway
from E. coli BL21(DE3) strain. As shown in Figure 3a, the (+)-zizaene titer of the TZS strain was the
lowest when compared to all the tested strains; however, it achieved the highest cell growth (biomass
2.9 g L−1 and cell density of OD600 7.2, Figure 3c,d) and amounts of soluble ZS protein (Figure 4b) for
the TZS strain induced at 0.1 mM IPTG. These observations suggest a low metabolic burden due to
the overexpression of a single recombinant protein (ZS). Moreover, it evidences the limited supply of
the endogenous FDP from E. coli, which is required for the biosynthesis of isoprenoid quinones and
peptidoglycans [13,14].
Figure 4. Evaluation of the overexpression of the soluble (SF) and insoluble (IF) ZS protein fractions
from the engineered E. coli BL21(DE3) strains, induced at different IPTG levels by 10% SDS-PAGE. (M)
molecular marker. * BZS+Mev induced with 1 mM IPTG and different levels of arabinose (Ara).
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3.2. Improving the Titers of (+)-zizaene through the Mevalonate Pathway
To raise the supply of the precursor FDP, the polycistronic pMevZS vector was constructed with
the ZS gene and the exogenous MEV pathway (Figure S1), which was obtained from the pMEV vector
that harbors the following genes: AtoB, HMGS*, tHMGR*, MK*, PMK*, PMD, IDI, and IspA (*genes from
S. cerevisiae that were codon-optimized to E. coli) [18]. Consequently, a single mRNA transcript was
expressed under the control of the lacUV5 promoter. As a result, overexpression of the heterologous
MEV pathway with the ZS gene (MevZS strain) induced with 0.1 mM IPTG augmented the (+)-zizaene
production and yield by 2.7 and 5-fold respectively when compared to the TZS strain (Figure 3a,b).
Thus, a relation was observed in both TZS andMevZS strains, where higher amounts of IPTG increased
the overexpression of insoluble ZS protein (Figure 4a,c). Moreover, overexpression of theMEV pathway
generated a strong metabolic burden, where cell growth diminished by 1.8-fold biomass and 2.1-fold
cell density when compared to that of the strain lacking the MEV pathway (TZS strain) (Figure 3c,d).
Although the overexpression of the MEV pathway raised the FDP supply, the production of soluble ZS
protein declined dramatically when compared to the TZS strain (Figure 4c), suggesting that the ZS
supply became the limiting factor.
3.3. Effect of Promoters on the Overexpression of the ZS Gene
The low ZS supply demonstrated by the MevZS strain could result from either expression
mechanisms of polycistronic vectors and, or by the promoter strength. To prove these hypotheses,
multi-vector strains were constructed harboring the following plasmids: polycistronic pMev vector
(MEV pathway) and monocistronic ZS vector ((+)-zizaene pathway). Two versions of the ZS vectors
were constructed in order to test the effect of promoters on the ZS supply. The designed ZS vectors
comprised the pETZS vector with the strong T7 promoter and the pJbeiZS vector harboring the weak
PBAD promoter (Figure S2). The overexpression of the ZS gene under the control of the PBAD promoter
(BZS+Mev strain) did not enhance the (+)-zizaene titers when compared to the MevZS strain, but it did
increase the (+)-zizaene yield by 2.5-foldwhen inducedwith 50mMarabinose (Figure 3b). Nevertheless,
the BZS+Mev strain showed the lowest cell growth of all the tested strains (biomass 0.63 g L−1 and
cell density of OD600 1.0, Figure 3c,d). Furthermore, overexpression of the ZS gene controlled by the
T7 promoter (TZS+Mev strain) raised the amounts of soluble ZS protein when compared to that of
the induced with the PBAD promoter (Figure 4d,e). As a consequence, the (+)-zizaene production and
yield augmented 7.2 and 4.4-fold, respectively when compared to the BZS+Mev strain, and 7.2 and
11.3-fold correspondingly when compared to the MevZS strain (Figure 3a,b). Such strategy improved
the ZS supply and consequently restored the flux balance of the (+)-zizaene biosynthesis.
3.4. Enhancing the ZS Supply by Engineering Multiple Copies of the ZS Gene
Overexpression of theZS genewith the T7 promoter seemed to overcome the ZS supply limitations
of the MevZS and BZS+Mev strains. Nevertheless, the optimal amount of ZS to catalyze the FDP
supply still remains unknown. To increase the ZS supply even further, a multi-vector strain that
harbored two copies of the ZS gene was engineered. For that, the TZS+MevZS strain was developed,
harboring the pETZS and pMevZS vectors, and controlling the expression of the ZS genes by the T7
and lacUV5 promoters. As a result, the multi-copy ZS gene strain achieved the best results of all the
constructed strains (titer: 13.7 mg L−1 and yield 11.6 mg g−1 DCW) and raised 1.3-fold the (+)-zizaene
titers and 1.6-fold the yields in comparison to the TZS+Mev strain (one ZS gene copy) (Figure 3a,b).
Moreover, it augmented the (+)-zizaene production and titer by 9.7 and 18.4-fold correspondingly
when compared to the single-vector MevZS strain. These results suggest that the bottleneck of the
metabolic flux was still the ZS supply, which could be improved by the combination of the T7 promoter
with multiple copies of the ZS gene, harbored on a multi-vector strain.
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3.5. Optimization of Fermentation Conditions and Evaluation of E. coli Strains
To raise further the production of (+)-zizaene, fermentation tests were carried out at shake flask
scale, comprising the evaluation of culture media, optimization of growth temperature and media
pH, and testing of E. coli strains. Accordingly, the mineral-salt defined media DNB, ADM, and M9
were tested due to their previous use in metabolic engineering studies and suitability to control
carbon-limited growth required for fed-batch or continuous cultivations to reach high-cell density
cultures [33]. To compare the performance of defined media against complex media, the TB broth was
used. As a result, substantial differences were observed between the defined media, where the highest
(+)-zizaene levels and yieldswere obtained byADMmedia, followed byDNB andM9media (Figure 5a).
Consequently, the ADMmedium was 1.8-fold higher than the DNB medium for the (+)-zizaene titers
and 1.2-fold higher for the (+)-zizaene yields. Both tested media were of similar formulation with the
exception of the trace elements and nitrogen composition, whereas the concentration of nitrogen of the
ADMmedium was 2.5-fold higher than the DNB medium. Likewise, cell growth followed a similar
behavior to that of the (+)-zizaene production among the tested media, where the complex TB broth
had the highest cell growth when compared to the defined media tests (Figure 5b). However, the ADM
medium obtained the highest (+)-zizaene yields (16.2 mg g DCW−1) when compared to all the tests
and was consequently selected for further tests.
Figure 5. Optimization of the fermentation conditions and testing of E. coli strains for the improvement
of the terpene performance. Evaluation of production media: (A) (+)-zizaene titers and yields,
(B) biomass and cell density. Optimization of growth temperature and media pH: (C) (+)-zizaene titers,
(D) (+)-zizaene yields. Evaluation of E. coli strains: (E) (+)-zizaene titers and yields, (F) biomass and
cell density. Data are the mean of four independent replicates from production cultures after 24 h of
induction, and the error bars represent the standard deviation.
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To further improve the fermentation conditions, factorial designs of two levels were implemented
for the optimization of growth temperature and pH of the ADM medium. Accordingly, optimal
(+)-zizaene levelswere found between 19.5-21.8 ◦CandpH6.8-7.08 (Figure 5c) and for (+)-zizaene yields
between 18-20.8 ◦C and pH 6.8-7.1 (Figure 5d). Temperature affected (+)-zizaene levels differently than
yields, whereas moderate (+)-zizaene levels (15-21 mg L−1) were shown at a broad range of temperature
(17.5-27.7 ◦C). On the contrary, pHhad nearly the same effect on both variables. Additionally, the highest
levels of soluble ZS protein were found at lower pH and temperatures (Figure 6b). Tests at pH 6.5
also produced the highest amounts of insoluble ZS protein, resulting in the lowest (+)-zizaene levels.
Similarly, tests carried out at 16 ◦C dropped the (+)-zizaene levels despite the high amounts of soluble
ZS protein, possibly due to enzymatic mechanisms. As a result, the optimal fermentation conditions
were determined as 20 ◦C and pH 7.0, which improved the (+)-zizaene levels to 21.5 mg L−1 and yields
to 16.2 mg g−1 DCW.
Figure 6. Analysis of the over-expression of soluble (SF) and insoluble (IF) ZS protein fractions from
the optimization of fermentation conditions and testing of E. coli strains by 10% SDS-PAGE. (A) Culture
media test. (B) Temperature and pH optimization. (C) E. coli strains test. (M) molecular marker.
Strain tests were carried out under optimal fermentation conditions (ADMmedium, 20◦ C and pH
7) to assess the features of the E. coli B strains SHuffle T7, SHuffle T7 lysY, Tuner(DE3) and BL21(DE3),
and measure their impact on the production of (+)-zizaene. The SHuffle-based strains were selected
to test if there could be an enhancement in the folding of ZS due to the effect of a disulfide bond
chaperone DsbC. Additionally, the SHuffle T7 lysY variant reduces the basal expression for toxic
genes through the expression of lysozyme, coded by the lysY gene. Similarly, the BL21(DE3) variant,
the Tuner(DE3) strain lacks the lacY gene that codes for the β-galactosidase permease, which allows
fine-tuning for induction and reduces basal expression. As a control, the BL21(DE3) strain was used.
As presented in Figure 5e, the differences between the BL21-based and SHuffle-based strains were
remarkable; unexpectedly, the best results were shown by the Tuner(DE3) strain, followed by the
BL21(DE3), SHuffle T7, and SHuffle T7 lysY strains. These observations demonstrate that the strains
expressing the lowest number of recombinant proteins produced the highest cell growth (Figure 5f),
and soluble ZS protein amounts (Figure 6c), and consequently, the highest (+)-zizaene titers and
yields (shown by increasing number of recombinant proteins: Tuner(DE3): ZS; BL21(DE3): ZS, lacY;
SHuffle T7: ZS, lacY, DsbC; SHuffle T7 lysY: ZS, lacY, DsbC, lysY). Overexpression of the chaperones by
the SHuffle-based strains did not have the expected results; instead, it showed deleterious effects as
observed from the low amounts of ZS protein. As a result, the strain that expressed the minimum
number of recombinant proteins, the Tuner(DE3) strain, enhanced 1.2-fold the (+)-zizaene levels and
1.4-fold the yields in comparison with the control BL21(DE3) strain.
Finally, the applied approach for the optimization of the fermentation conditions improved the
(+)-zizaene titers 2.2-fold and yields 1.7-fold when compared to the strains without optimization
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(Section 3.4), achieving the highest (+)-zizaene production of 25.09 mg L−1 and yield 23.33 mg g−1
DCW for this study.
4. Discussion
The production of (+)-zizaene was metabolically engineered in E. coli by a recombinant
codon-optimized SUMO-fused ZS that enhanced the amounts of soluble ZS protein [10].
Moreover, the optimization of the metabolic flux to (+)-zizaene was the greatest challenge, where the
FDP and ZS supply were identified as the limiting factors. Consequently, a strategy was applied to
gradually increase the supply of both and augment the metabolic rate driving force towards (+)-zizaene.
Initially, production of (+)-zizaene was possible by using the endogenous MEP pathway from
E. coli (TZS strain) but at a lower extent. The high amounts of soluble ZS protein and low titers of
(+)-zizaene suggest a limitation on the FDP supply. For that reason, the exogenous MEV pathway was
applied, which is the ubiquitous pathway in plants for the biosynthesis of the sesquiterpene substrate
FDP [34]. Hence, the pMevZS vectorwas constructed as a polycistronic vector, including all the required
genes for terpene production into one vector. Such a strategy has been used for the engineering of many
terpenes [23,28,35] because the maintenance of a single vector by the host cells is more efficient than
for multi-vectors [36]. As a result, the overexpression of the MevZS strain did not increase the levels of
(+)-zizaene as expected; possibly due to the lower amounts of soluble ZS protein than the TZS strain.
This could be explained by the moderate strength of the lacUV5 promoter [37], theimproved variant
of the lac promoter from E. coli [38]. Additionally, the ZS gene was placed eight genes downstream
from the promoter in the polycistronic pMevZS vector and eventually, this gene order could affect the
overexpression of ZS, as demonstrated by other studies [39–41]. Moreover, the overexpression of the
nine genes produced a large mRNA transcript, which is usually more unstable as short transcripts [42].
Thus, the increase in the FDP supply and the decline in the soluble ZS protein amounts suggest that
the limiting factor shifted to the ZS supply. This scenario was deleterious for an optimal metabolic rate,
because ZS suffers substrate inhibition from FDP at higher levels of 5 µM, as shown in our previous
report [20].
To raise the ZS supply, the monocistronic vectors pJbeiZS and pETZS were designed by cloning
the ZS gene directly after the promoter and further co-transformed into the strain with the pMev vector.
The use of the BZS+Mev strain was initially promising because it is capable of tuning the metabolic flux,
using unique inducers for FDP (IPTG) and ZS (Arabinose). However, results with the PBAD promoter
were similar to those obtained by the MevZS strain, possibly due to the similarity in the strength of the
PBAD promoter versus the lacUV5 promoter [37]. Similar outcomeswere demonstrated by others, where
the lacUV5 and PBAD promoters produced low or even undetectable levels of sesquiterpenes [11,12].
Additionally, accumulation of toxic intermediates due to a highermetabolic burden could occur because
the BZS+Mev strain harbors the high-copy pJbeiZS plasmid with the pBBR1 origin of replication [43].
On the other hand, overexpression of soluble ZS protein with the T7-promoter (TZS+Mev strain) was
drastically higher than with the PBAD promoter (BZS+Mev strain) and subsequently, the production of
(+)-zizaene increased considerably.
We ventured to raise further the ZS supply by adding a second copy of the ZS gene through the
TZS+MevZS strain. As a result, the production of (+)-zizaene was the greatest of all the engineered
strains and suggests that the limiting factor was still the ZS supply. The improvement in (+)-zizaene
levels could be due to the effect of overexpressing the ZS genes by two different promoters on two
different vectors (T7 in pETZS and lacUV5 in pMevZS). Such strategy could have been a contributive
factor, possibly by overexpressing the ZS gene by different promoters, by RBS strength differences
from the used vectors, and by the vector copy numbers, which are unequal on multi-plasmid
strains due to differences between replication origins, antibiotic markers, and plasmid sizes [16,42].
However, more tests are required to draw such conclusions. Additionally, it seems that the in vivo
production of (+)-zizaene requires higher amounts of the TPS when compared to other sesquiterpenes
such as vetispiradiene (KM = 0.7µMfor the vetispiradiene synthase) [44], due to the low enzyme activity
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of ZS (KM = 0.88 µM) [20]. Therefore, increasing the copy number of the TPS gene in a multi-vector
strain was a plausible strategy to improve the flux to (+)-zizaene.
Optimal fermentation conditions are crucial for efficient microbial growth and metabolization
of glucose flux towards terpenes, as demonstrated by many reports [11,45,46]. Regarding the media
evaluation, the ADMmedium achieved the highest production of (+)-zizaene when compared to the
other defined media tests. The main difference in media formulation between tests was the higher
amount of nitrogen from the ADM medium, suggesting that nitrogen concentration was the most
relevant factor; particularly, because nitrogen is required for the biosynthesis of amino acids that
regulates the production of cellular and recombinant proteins [47]. This could explain the higher cell
growth and soluble ZS protein levels from the ADMmedium tests when compared to the other tests,
which in turn improved the (+)-zizaene levels.
Optimization of the temperature and media pH can enhance the production of sesquiterpene as
observed with the microbial production of vetispiradiene, 5-epi-aristolechene and (+)-δ-cadinene [11].
For the production of (+)-zizaene, the optimal fermentation conditions were found at 20 ◦C and
pH 7.0, which differ from the optimal reaction conditions from the ZS in in vitro biotransformations
with FDP (36 ◦C, pH 7.5) [20]. Thus, the greatest difference between the experimental conditions
was the temperature, due to its relevant effect over protein synthesis rate, cell growth, and enzyme
activity [11,48]. Accordingly, tests cultivated at 16 ◦C and pH 6.5-7, overexpressed high amounts of
soluble ZS protein but the (+)-zizaene levels and cell growth were low. These results suggest that the
activity of the ZSwas drastically reduced at 16 ◦C, due to its preference for higher temperatures (optimal
at 36 ◦C). On the other hand, temperatures higher than 20 ◦C resulted in higher amounts of insoluble
ZS protein than the soluble form. These observations confirm that an optimal temperature of 20 ◦Cwas
required to achieve a balance between cell growth and active ZS protein. Regarding the effect of the
media pH on (+)-zizaene production, the optimal pH was found to be neutral pH and values different
than that lowered the (+)-zizaene titers. Additionally, lower pH values promoted the formation of
insoluble ZS protein. Such behavior was observed before in uncontrolled-pH E. coli cultures grown in
shake flasks, whereas overexpression of fused SpA-βgal protein at pH < 5.5 augmented the inclusion
body formation, possibly due to regulatorymechanisms for pHhomeostasis [49]. Therefore, tests grown
at pH 7 at 20 ◦C achieved the balance between insoluble and soluble ZS protein fractions that led to the
highest production of (+)-zizaene.
The evaluation of E. coli B strains revealed considerable differences in terpene production due to
the particular feature of each strain. The terpene performance increased with the strains that expressed
the lower number of recombinant proteins such as the BL21(DE3)-based strains. These results
suggest that the expression of the ZS protein is not affected by basal expression (lysY gene), neither
the β-galactoside permease is required (lacY gene), nor the chaperon DsbC enhanced the protein
folding and disulfide bond formation, although the ZS protein contains cysteines. On the contrary,
overexpression of DsbC drastically dropped the amounts of soluble ZS protein and the (+)-zizaene
titers. Consequently, the Tuner(DE3) strain achieved the best performance for terpene production
by overexpressing the minimum number of recombinant proteins, thus avoiding the production of
unnecessary proteins (β-galactoside permease, DsbC, and lysozyme). This strategy diminished the
metabolic burden, defined as the resources consumed for cell maintenance and recombinant protein
synthesis that is inversely proportional to cell growth [48]. This was confirmed by the higher biomass
amount from the Tuner(DE3) strain when compared to the other tested strains. As a result, the lower
metabolic burden from the Tuner(DE3) strain improved the efficiency of the carbon flux towards
(+)-zizaene.
5. Conclusions
In thiswork, we demonstrated themetabolic engineering ofE. coli strains for the in vivo production
of (+)-zizaene. Moreover, we optimized the limiting factors of the metabolic flux to (+)-zizaene by the
overexpression of the MEV pathway, and by boosting the ZS supply by increasing the number of copies
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of the ZS gene with T7 promoters on a multi-plasmid strain. Final improvement was achieved by
optimizing the fermentation conditions and testing of E. coli B strains to a final (+)-zizaene production
of 25.09 mg L−1 at the shake flask scale. This work offers new insights into the optimization of the
metabolic pathway and fermentation conditions for the in vivo production of sesquiterpenes and the
development of a novel microbial platform towards the industrialization of fragrant molecules.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/10/6/478/s1,
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Table S1: Mass spectra of the identified products.
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4.3. External and internal in situ product recovery of sesquiterpene (+)-zizaene produced 
from metabolically engineered E. coli 
Recent progress in metabolic and bioprocess engineering has made possible the biotechnological 
production of terpenes at industrial levels. After a high investment in R&D, several chemical 
companies have deployed distinct terpenes to the market, produced from microbial platforms 
such as artemisinin, β-farnesene, nookatene, patchouli oil, valencene, sclareol and squalane. 
Among the challenges involved in the microbial production of terpenes is the product recovery 
from fermentation. The ubiquitous physical-chemical properties of terpenes such as 
hydrophobicity and volatility are the main constraints for the downstream process. As a result, 
the biotechnological production of the khusimol precursor, (+)-zizaene, suffers from such 
constraints during fermentation. In the previous chapter, the application of metabolic 
engineering methods made possible the production of (+)-zizaene by a multi-plasmid E. coli 
strain. Thus, this chapter addresses the development of a suitable method for the (+)-zizaene 
recovery in fed-batch fermentations at bioreactor scale. 
Initially, the questions were, whether a loss of (+)-zizaene due to volatilization could exist, and 
eventually, how much could be lost. Experiments with cell-free media containing (+)-zizaene 
amounts were carried out at shake flask scale. After 60 min of incubation at 20 °C, more than half 
of the (+)-zizaene amounts were volatilized, ruling out the microbial degradation as main 
mechanism for (+)-zizaene loss. Furthermore, product loss by volatilization was measured as 27 
mg L‒1 by comparing cultivations without extractants and with liquid-liquid phase partitioning 
cultivation (LLPPC) with a solvent as overlay after 48 h of growth. 
The solid-liquid phase partitioning cultivation (SLPPC) by polymeric adsorbers was analyzed 
due to the advantages against LLPPC such as ease of adsorber removal, non-emulsion formation 
and reusability. As a result, the Diaion HP20 adsorber obtained the highest recovery ratio of all 
the tested adsorbers with results similar to that by LLPPC. Additionally, an evaluation of organic 
solvents was tested for the desorption of (+)-zizaene from the Diaion HP20 adsorbers. The 
isooctane, decane and ethyl acetate demonstrated the highest (+)-zizaene elution when compared 
to the rest of the tested solvents, whereas isooctane was chosen for further tests due to its low 
cost.  
The bioprocess of (+)-zizaene was scaled up to 2 L stirred-tank bioreactors with fed-batch 
cultivations by integrating the in situ (+)-zizaene recovery to the fermentation. The external 
recovery configuration (ERC) was designed with an external loop connected to an external bed 
adsorption (EBA) column and improved the (+)-zizaene titer 2.5-fold more than the LLPPC at 
shake flask scale. The internal recovery configuration (IRC) with adsorbers inside the reactor 
further improved the (+)-zizaene titers 2.2-fold more when compared to that of the ERC. An 
additional test by the internal recovery configuration with gas stripping (IRC+GS) confirmed an 
efficient product recovery from the IRC, and the gas stripping was considered unnecessary for 
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the bioprocess due to the contribution of less than 1% to the total (+)-zizaene amount. 
Consequently, the IRC improved the (+)-zizaene titer 8.4-fold and productivity 3-fold when 
compared to the highest result from chapter 2 (25 mg L−1), and achieved the highest (+)-zizaene 
production (211 mg L−1) reported so far. Finally, the in situ recovery configurations tested in this 
study are suitable methods for the recovery of (+)-zizaene and provide new insights for other 
bioprocesses towards the microbial production of fragrant sesquiterpenes. 
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Abstract: The sesquiterpene (+)-zizaene is the direct precursor of khusimol, the main fragrant
compound of the vetiver essential oil fromChrysopogon zizanioides and used in nearly 20% ofmen’s fine
perfumery. The biotechnological production of such fragrant sesquiterpenes is a promising alternative
towards sustainability; nevertheless, product recovery from fermentation is one of themain constraints.
In an effort to improve the (+)-zizaene recovery from a metabolically-engineered Escherichia coli,
we developed an integrated bioprocess by coupling fermentation and (+)-zizaene recovery using
adsorber extractants. Initially, (+)-zizaene volatilization was confirmed from cultivations with
no extractants but application of liquid–liquid phase partitioning cultivation (LLPPC) improved
(+)-zizaene recovery nearly 4-fold. Furthermore, solid–liquid phase partitioning cultivation (SLPPC)
was evaluated by screening polymeric adsorbers, where Diaion HP20 reached the highest recovery.
Bioprocess was scaled up to 2 L bioreactors and in situ recovery configurations integrated to
fermentation were evaluated. External recovery configuration was performed with an expanded bed
adsorption column and improved (+)-zizaene titers 2.5-fold higher than LLPPC. Moreover, internal
recovery configuration (IRC) further enhanced the (+)-zizaene titers 2.2-fold, whereas adsorption
velocity was determined as critical parameter for recovery efficiency. Consequently, IRC improved
the (+)-zizaene titer 8.4-fold and productivity 3-fold from our last report, achieving a (+)-zizaene
titer of 211.13 mg L−1 and productivity of 3.2 mg L−1 h−1. This study provides further knowledge for
integration of terpene bioprocesses by in situ product recovery, which could be applied for many
terpene studies towards the industrialization of fragrant molecules.
Keywords: (+)-zizaene; khusimene; khusimol; vetiver essential oil; in situ product recovery; expanded
bed adsorption; sesquiterpenes; terpenes; Chrysopogon zizanioides
1. Introduction
The biotechnological production of chemicals by engineered microorganisms is a potential
alternative for the production of terpenes from renewable resources [1]. Recent advances in
metabolic engineering have made possible the production of terpenes by microbial platforms at
economically-feasible titers (over grams of terpene per liter of broth), reaching the industrial scale,
such as artemisinin, β-farnesene, and squalane [2–4]. Fragrant sesquiterpenes used in the cosmetic
industry are potential candidates to be produced by biotechnological systems, such as the sesquiterpenes
contained in the vetiver essential oil (VEO) from the grass Ch. zizanioides. VEO is an important
component for the formulation of cosmetics and it has been used in nearly 36% of Western perfumes
and 20% of men’s fragrances [5] with a total world production of 300−350 tons per year [6]. VEO is
composed of a mixture of sesquiterpenes and their hydroxylated derivatives, with a characteristic
Molecules 2019, 24, 3356; doi:10.3390/molecules24183356 www.mdpi.com/journal/molecules
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dark woody scent granted principally by khusimol, its main fragrant component [7,8]. Moreover, the
biotechnological production of khusimol could lead to a reliable supply for the cosmetic industry and
to avoid the shortages from the traditional supply of VEO (extracted from the vetiver roots) due to
natural disasters such as earthquakes and floods [6,7].
An important step towards themicrobial production of khusimolwas thewhole-cell bioproduction
of (+)-zizaene (syn. khusimene), the direct precursor of khusimol, by a metabolically-engineered
strain of E. coli [9]. This was demonstrated by engineering the mevalonate (MEV) pathway to increase
the levels of the natural sesquiterpene precursor E,E-farnesyl diphosphate (FDP) and overexpressing
the (+)-zizaene synthase (ZS) [9]. The latter terpene synthase catalyzes the substrate FDP through
a complex reaction by carbocation rearrangements and cyclizations to yield the tricyclic (+)-zizaene
with a product specificity over 90% [10].
Further development of the (+)-zizaene bioprocesswould comprise the scale-up of the fermentation
to bioreactors (upstream process) and the product recovery (downstream process). As usually,
the scale-up of the fermentation is performed by optimizing the bioreactor variables such as pH,
oxygen supply, and stirring [11]. Additionally, scale-up studies can be performed using fed-batch
fermentation by feeding of a carbon source, such as glucose, to reach high cell density cultures (HCDC),
as is the case with the production of farnesene, santalene, cucurbitadienol, and (-)-α-bisabolol [12–14].
The downstream process is one of the main challenges towards the industrialization of terpenes
because of their inherent physicochemical properties such as hydrophobicity and volatility [15].
Such bioprocesses often suffer cell toxicity, product inhibition, product volatilization, and product
degradation, which can be devastating for the bioprocess productivity [16]. As an alternative, in situ
product recovery (ISPR) has been applied for the downstreaming of terpenes, defined as the removal
of product during its formation in the reactor [17].
The liquid–liquid phase partitioning cultivation (LLPPC) is the most used ISPR technique for
terpene recovery, in which the fermentation is carried out with a liquid extractant, forming two
immiscible phases [15]. The liquid extractants are usually bio-compatible organic solvents with a high
log P value that do not partition into the microbial membrane and sequester the terpenes from the
aqueous phase [18,19]. Because of the ease of LLPPC, it is the first choice for ISPR of terpenes and it has
been applied in the recovery of many terpenes such as limonene [20], taxadiene [21], α-santalene [22],
and amorpha-4,11-diene [23].
Another ISPR alternative is the solid–liquid phase partitioning cultivation (SLPPC), inwhich a solid
extractant is in contact with the fermentation, such as polymeric adsorbers, porous resins, zeolites, or
activated charcoal [24]. Due to their high affinity to hydrophobic compounds, these extractants can
selectively adsorb terpenes and can be applied in numerous configurations because of their mechanical
stability [15], as implemented for the production of perillylic alcohol [25], epi-cedrol [26], and linalool
oxides [27].
The mechanisms for ISPR of terpenes in E. coli are described in Figure 1 for both LLPPC and
SLPPC. Accordingly, terpenes are synthesized in the cell cytosol and exported to the fermentation
broth by solvent-resistant tripartite efflux pumps such as AcrAB-TolC andMdtEF-TolC [28,29]. For the
LLPPC, terpenes are extracted into the organic solvent by the principle of hydrophobic interactions,
in which non-polar hydrocarbons form aggregates together and separate from the aqueous phase [30].
In the case of SLPPC, terpenes are adsorbed to the porous surface of the solid extractant whether by
physisorption or chemisorption, forming a film in the porous surface of the extractant, without altering
the terpene structure [31]. Eventually, factors such as the chemical structure of the adsorber, pore size,
particle size, and specific surface area will affect the adsorption efficiency [32].
Regardless of whether LLPPC or SLPPC is used, the configurations for ISPR of terpenes can be
applied internally or externally in a direct or indirect approach [33]. Internal recovery configuration
(IRC) is based on the extractant phase inside the reactor vessel, whereas in the external recovery
configuration (ERC), the fermentation broth is recirculated towards an external loop to an extractant
unit, such as an expanded bed adsorption (EBA) column [16]. In consequence, the choices for ISPR of
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terpenes are vast, whereas commercial processes employ a single or a combination of ISPR techniques,
including adsorption recovery and/or gas phase recovery (gas stripping) [34]. However, the choice of
configuration depends greatly on the downstream cost, which is determined by several factors such as
the cost of extractant, number of phases, and recovery process, which will be related to the properties
of the target molecule [33,35]. Moreover, ISPR provides numerous advantages when compared to the
traditional extraction of terpenes and contribute towards a greener chemistry by reducing the recovery
stages, amounts of solvents, and extracting products under milder conditions, which results in the
reduction of the downstream costs [36].
 
− −
Figure 1. The mechanism for the in situ recovery of terpenes produced from metabolically engineered
E. coli. (A) Liquid-liquid phase partitioning cultivation is carried out by liquid extractants (organic
solvents), which extract the terpenes by hydrophobic interactions. (B) Solid-liquid phase partitioning
cultivation utilizes solid extractants (adsorbers) and recovers the terpenes by adsorption. The tripartite
efflux pump AcrAB-TolC is used as an example of a secretion system for hydrophobic molecules and its
components are properly described.
In our previous report, we demonstrated the production of (+)-zizaene by a metabolically-
engineered E. coli and optimized the fermentation conditions at shake flask scale, comprising the
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induction, media, pH, and growth temperature, reaching a (+)-zizaene titer of 25.09 mg L−1 and
a productivity of 1.05 mg L−1 [10]. However, the scale-up for the bioprocess of (+)-zizaene requires
a suitable ISPR configuration to circumvent product loss and further improve the recovery of (+)-zizaene.
In this study, we developed an integrated ISPR configuration for the microbial production of
(+)-zizaene at a 2 L bioreactor scale with adsorber extractants in order to improve the (+)-zizaene
recovery. For that, the product loss by volatilization was analyzed and the (+)-zizaene recovery
was improved by using LLPPC at shake flask scale. Furthermore, distinct polymeric adsorbers
were evaluated, in terms of selectivity and recovery ratio, as potential extractants to be applied at
bioreactor scale. The desorption process was studied by a comparative assessment of organic solvents.
The bioprocess was scaled up to 2 L bioreactors using the fed-batch culture technique and three ISPR
configurations by direct contact mode were tested: ERC, IRC, and IRC with gas stripping. As a result,
the (+)-zizaene titers and productivity were improved significantly.
2. Results
2.1. Product Volatilization Measurements and (+)-Zizaene Recovery by LLPPC
In our previous report, we demonstrated the microbial production of (+)-zizaene by engineering
the MEV pathway and the ZS synthase in a multi-plasmid E. coli strain [9]. To further improve the
production of (+)-zizaene, the bioprocess development requires the scale-up to stirred-tank bioreactors
to reach HCDC, and an efficient downstream procedure. However, the recovery of terpenes involves
special considerations due to their physicochemical properties. For the production of (+)-zizaene, loss of
product could be expected during cultivation due to volatilization or microbial degradation. Moreover,
toxicity to the E. coli cells could occur because of (+)-zizaene accumulation in the fermentation.
Initially, we analyzed the loss of (+)-zizaene at shake flask scale without extractants by cultivating
an induced E. coli TZS+MevZS strain, grown for 24 h. After removing the cells from the culture
broth, (+)-zizaene measurements were taken time-wise from cell-free media. As a result, half of
the (+)-zizaene amount was volatilized after 1 h and only traces were detected after 4 h (Figure 2).
This demonstrates that, as for most terpenes, volatilization is a major constraint for the (+)-zizaene
production. Eventually, the application of ISPR could provide solutions for these shortcomings, taking
advantage of the hydrophobicity of (+)-zizaene (log P = 5.10), which could be extracted simultaneously
during cultivation whether by liquid- or solid-phase recovery.
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Figure 2. Loss of (+)-zizaene by volatilization on cell-free media at shake flask scale. Data are the mean
of three replicates with error bars representing the standard deviation (SD).
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To prove these hypotheses, a comparative test comprising a LLPPC with a solvent overlay and
a negative control (without extractant) was performed with the E. coli TZS+MevZS strain at shake flask
scale. As shown in Figure 3A, the (+)-zizaene production on the LLPPC and negative control tests
followed similar kinetics, reaching the maximum peak at 48 h and dropping afterward. The LLPPC
was nearly 4-fold higher when compared to that of the negative control at the highest production
peak. Therefore, the loss of (+)-zizaene was estimated at nearly 27 mg L−1 due to volatilization at
48 h. Similarly, cell growth was higher on the LLPPC (OD600 5.7 and biomass 2.1 gDCW L
−1) than
the negative control (OD600 5.1 and biomass 1.7 gDCW L
−1) at 48 h, suggesting a toxic effect due to
(+)-zizaene accumulation in the control tests (Figure 3B).
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Figure 3. Comparison of the (+)-zizaene production (A) and growth kinetics (B) between the
liquid-liquid phase partitioning cultivation (LLPPC) and the control (-) without extractant from
the E. coli TZS+MevZS strain. Plots correspond to the mean of three independent experiments with
error bars as SD.
2.2. Screening of Polymeric Adsorbers for SLPPC
Although LLPPC has been used widely for isoprenoid recovery, SLPPC with solid extractants
can be advantageous towards the scale-up of bioprocesses due to the following features: reusability,
bio-compatibility, cost reduction of organic solvents, non-emulsion formation, and simple separation
from the aqueous phase [15,37,38]. Thus, an in vivo adsorber screening analysis was carried out based
on Halka [11] at shake flask scale. The tested polymeric adsorbers were chosen according to their
affinity to adsorb hydrophobic molecules, as demonstrated in previous terpene recovery studies [25,39].
A negative control without extractants and a LLPPC control were also included.
As a result, the adsorbers showed similar product selectivity, where the terpene profile for all
the tested adsorbers by GC-MS showed approximately a product ratio of 90% of (+)-zizaene, 9.5% of
β-acoradiene, and traces of hydrocarbons (Figures S1 and S2).
The tested adsorbers presented significant recovery differences, where the Diaion HP20 test
achieved the highest (+)-zizaene titer from all the tested resins, followed by Amberlite XAD4, Amberlite
XAD16N, Lewatit 1064MD and Amberlite IRA400 Cl tests (Figure 4A). Moreover, the (+)-zizaene
recovery ratio from Diaion HP20 was similar to that obtained by the LLPPC control (92.5% vs. 94.4%,
respectively) (Table S2).
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Figure 4. Screening of distinct polymeric adsorbers for the recovery of (+)-zizaene. (A) (+)-zizaene
titers recovered from cells, cell-free media, and adsorbers. (B) Cell growth expressed by biomass and
cell optical density. The negative control corresponds to culture without extractants. Data are the mean
of three replicates with error bars as SD. Variables analyzed by ANOVA (α = 0.05), letters that differ are
significantly different.
Besides theAmberlite IRA400Cl test, the rest of the adsorber tests recoveredmost of the (+)-zizaene
amounts from the adsorbers (75.2%–92.5%), followed by the cell-free media (4.5%–18.7%) and in
lower amounts from the cells (3.1%–6.1%; Table S2). As expected, only low (+)-zizaene amounts were
measured from cell-free media by the negative control, confirming a loss of (+)-zizaene by volatilization.
Besides, the highest amount of insoluble (+)-zizaene protein (inclusion bodies) was observed on the
negative control, whereas most of the tested adsorbers and LLPPC showed low amounts of inclusion
bodies (Figure S3).
All of the tested adsorbers obtained similar cell growth between OD600 3.4–3.9 and biomass
0.96–1.17 gDCW L
−1 from the E. coli TZS+MevZS strain (Figure 4B). On the other hand, the negative
control (without extractant) had a lower cell growthwhen compared to all the other tests, with an OD600
of 2.7 and biomass of 0.7 gDCW L
−1, suggesting a toxic effect from the (+)-zizaene amounts in the
culture broth. Because of the high recovery performance from the Diaion HP20 between adsorbers and
comparable results with the LLPPC control, the Diaion HP20 was selected for further cultivations.
2.3. Assessment of Organic Solvents for the Desorption of (+)-Zizaene
After the screening of adsorbers for the SLPPC, an evaluation was done to analyze the elution
performance of different organic solvents, which ideally should have a high partition coefficient and
high selectivity towards (+)-zizaene [19]. Consequently, distinct solvents with high log P values were
tested comprising decane, dodecane, pentane, ethyl acetate, isopropanol, isooctane, and acetonitrile
(Table S1).
As evidenced in Figure 5, the organic solvent tests displayed significant desorption differences,
with (+)-zizaene titers between 15–25 mg L−1 approximately. The eluents isooctane, decane, and ethyl
acetate recovered the highest (+)-zizaene titers (25.7, 24.7, and 24.0 mg L−1, respectively), followed by
dodecane, pentane, acetonitrile, and isopropanol. As a consequence, isooctane was selected as the
elution solvent and further used for scale-up tests.
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Figure 5. Elution performance of distinct organic solvents for the desorption of (+)-zizaene from the
adsorber Diaion HP20. Data correspond to the mean of three independent experiments with error bars
as SD. Data analyzed by ANOVA (α = 0.05), letters that differ are significantly different.
2.4. Integration of In Situ Recovery of (+)-Zizaene to Fermentation at Bioreactor Scale
The fermentation was scaled up to 2 L stirred-tank bioreactors using the fed-batch cultivation
method by feeding glucose continuously to reach HCDC. Because the use of liquid extractants is
challenging for industrial-scale bioreactors [15,33], we tested the (+)-zizaene recovery with solid
extractants. Thus, the external, internal, and internal with gas stripping in situ recovery configurations
(Figure 6) were integrated to the fermentation with the best performing adsorber (Diaion HP20) and
eluent (isooctane), in order to maximize product recovery and avoid cell toxicity, which could be more
problematic at bioreactor scale due to the higher production of (+)-zizaene.
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Figure 6. Diagramwith the distinct bioreactor configurations used for the in situ recovery of (+)-zizaene.
(A) External recovery: Adsorbers in expanded bed adsorption (EBA) column by an external loop.
(B) Internal removal: Adsorbers inside the bioreactor vessel. (C) Internal removal with gas stripping:
Adsorbers inside the bioreactor vessel and adsorption column coupled to the off-gas. Sample ports for
adsorbers are indicated.
The Diaion HP20 adsorber was used at 50 g L−1, whereas higher amounts resulted in mixing
problems and reading disturbances from the probes of the bioreactors. The optimal fermentation
conditions for (+)-zizaene production at shake flask scale were previously determined [9] and used
as the initial point for the bioreactor cultivations (ADM, pH 7.0), including induction at 20 ◦C to
avoid formation of inclusion bodies from the ZS protein and to reduce volatilization of (+)-zizaene.
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Early induction was applied in all cultivations (OD600 5–7) because late induction (OD600 > 15) was
proven deleterious for the (+)-zizaene production, where most of the ZS protein was overexpressed as
inclusion bodies (data not shown).
2.5. Bioreactor Cultivation with an Integrated ERC
The ERCwas analyzed because external loops can facilitate product removal from large bioreactors
and enable semi-continuous product recovery [15,38]. Moreover, the EBA chromatography was
preferred as the extractant unit over the conventional packed-bed adsorption chromatography, because
it allows operations at higher flow rates [40]. For this purpose, a stainless steel EBA column was built
with the feature of a sampling port to ease the process monitoring and adsorber renovation (Figure 6A).
The EBA was loaded with 75 g of Diaion HP20 and exchanged with 75 g of fresh resin every 24 h
of operation.
The fed-batch stage started at 7 h of growth by lowering the temperature to 20 ◦C, and after
1 h the culture was induced with 0.5 mM ITPG (Figure 7B). Afterwards, the recirculation through
the external loop (EBA) was initiated at a flow rate of 150 ml min−1. Thereafter, the production of
(+)-zizaene and cell growth increased proportionally from 12 to 72 h of culture (Figure 7A), showing
a coupling between both variables with a Pearson coefficient (PI) of 0.99. After 72 h of growth, the
maximum production peak was observed, reaching a (+)-zizaene titer of 93.4 mg L−1 and an OD600 of
43.0. Therefore, the bioprocess improved the (+)-zizaene titer 2.5-fold and the cell growth 7.5-fold when
compared to that of the LLPPC at shake flask scale. At the end of the cultivation (72 h), the recovery
ratio (94.6%) from the adsorbers was similar to that obtained from the LLPPC test from Section 2.2
(94.4%), followed from the cell-free media (3.0%) and from the cells (2.4%).
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Figure 7. Production of (+)-zizaene (A) and growth kinetics (B) in 2 L bioreactor with external recovery
configuration (ERC). Dotted line indicates division between batch and fed-batch stages.
2.6. Bioreactor Cultivation with an Integrated IRC
The IRC was evaluated as an alternative to improve the (+)-zizaene recovery further, whereas the
configuration was designed to recover (+)-zizaene directly from the culture broth and improve the
adsorption velocity (Figure 6B). To maintain the same amount of resin as the ERC, the bioreactor was
loaded with 75 g of adsorbers.
Similar to the ERC, a positive correlation between (+)-zizaene levels and cell growth was observed
from 12 to 72 h (PI = 0.98) (Figure 8B). Moreover, the production of (+)-zizaene increased after 24 h,
achieving the highest (+)-zizaene titer of 207.8 mg L−1 and cell growth (OD600 48.9 and biomass
10.3 gDCW L
−1) at the end of the fermentation (Figure 8A). Thus, the IRC improved the (+)-zizaene
titers 2.2-fold when compared to that of the ERC. In addition, the (+)-zizaene recovery ratio from
adsorbers was improved to 98.4% when compared to the ERC and reduced the amounts of (+)-zizaene
from cell-free media (0.9%) and cells (0.7%).
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Figure 8. Production of (+)-zizaene (A) and growth kinetics (B) in 2 L bioreactor with internal recovery
configuration (IRC). Dotted line indicates division between batch and fed-batch stages.
2.7. Bioreactor Cultivation with an Integrated IRC+GS
As discussed in Section 2.1, there was a loss of (+)-zizaene by volatilization at shake flask scale,
which could be even higher at bioreactor scale due to the gassing of air through the bioreactor
vessel. Therefore, the (+)-zizaene recovery from the off-gas of the bioreactor could be considered as
an additional recovery source to enhance the accumulative (+)-zizaene recovery from the fermentation.
For that, a variant from the IRC was performed with the addition of a column loaded with 75 g L−1 of
adsorbers and installed in the off-gas of the bioreactor (Figure 6C).
Similar to the other bioreactor configurations, the correlation between cell growth and (+)-zizaene
production on the IRC+GS was positive with PI = 95%, indicating a coupling between both variables.
The results were similar to the IRC test, where after 72 h of culture, the maximum cell growth (OD600
45.3 and biomass 9.7 gDCW L
−1) and (+)-zizaene production (203.4 mg L−1) were reached (Figure 9A,B).
The (+)-zizaene amounts were not detected on the ethanol trap, demonstrating efficient adsorption of
(+)-zizaene from the resins in the off-gas column with a (+)-zizaene recovery ratio of 0.6%. These low
amounts of (+)-zizaene detected on the off-gas suggest an efficient (+)-zizaene trapping from the
adsorbers in the culture broth, showing a recovery ratio from adsorbers of 97.6% and a low recovery
ratio of 0.9% from both cell-free media and cells, similar to the IRC.
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Figure 9. Production of (+)-zizaene (A) and growth kinetics (B) in 2 L bioreactor with internal
recovery configuration with gas stripping (IRC+GS). Dotted line indicates division between batch and
fed-batch stages.
2.8. Accumulative (+)-Zizaene Production from the Bioreactor Configurations
The contribution to the accumulative (+)-zizaene amount from the IRC+GS was low (less than
1%). In consequence, the IRC and the IRC+GS showed similar accumulative (+)-zizaene levels during
the course of the fermentation, whereas the difference between the ERC and both IRCs increased after
12 h of cultivation (Figure 10).
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The comparison of performance between bioreactor configurations is summarized in Table 1.
The accumulative (+)-zizaene titer and productivity between the IRC and IRC+GS were more than
2-fold higher than the ERC at 72 h of cultivation. Although differences between cell growth and
product yield (YX/S) were not so drastic between IRCs and ERC, the production of soluble ZS protein
from the IRCs was roughly 4-fold higher when compared to the ERC, suggesting a relation between
the soluble ZS protein and the (+)-zizaene levels. In consequence, the best configuration for the in situ
recovery of (+)-zizaene at bioreactor scale was the IRC; achieving an accumulative (+)-zizaene titer of
211.13 mg L−1 and productivity of 3.2 mg L−1 h−1. Moreover, these results improved the (+)-zizaene
titers 8.4-fold and productivity 3-fold when compared to those from our last report [10].
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Figure 10. Accumulative production of (+)-zizaene at 2 L bioreactors by distinct in situ recovery
configurations: External extraction (ERC), internal extraction (IRC), and internal extraction with gas
stripping (IRC+GS). Data are the means of three sample replicates with error bars as SD.
Table 1. Comparison of the bioprocess-performance variables between distinct bioreactor configurations
for the in situ recovery of (+)-zizaene after 72 h of growth.
Variable ERC IRC IRC+GS
Accumulative titer (mg L−1) 98.78 ± 3.87 211.13 ± 1.97 208.41 ± 7.29
Titer from adsorbers (mg L−1) 93.42 ± 3.30 207.84 ± 1.68 203.44 ± 6.89
Productivity (mg L−1 h−1) 1.50 ± 0.06 3.20 ± 0.03 3.16 ± 0.11
YP/X
1 (mgzizaene gDCW
−1) 12.32 ± 0.56 20.45 ± 6.98 21.41 ± 2.29
YX/S
2 (gDCW gglucose
−1) 0.22 ± 0.003 0.28 ± 0.11 0.30 ± 0.02
YP/S
3 (mgzizaene gglucose
−1) 2.69 ± 0.08 5.82 ± 0.09 6.52 ± 0.18
Soluble ZS protein (mg L−1) 35.42 ± 3.20 143.20 ± 2.95 129.80 ± 6.51
Adsorber recovery ratio (%) 94.60 ± 0.14 98.40 ± 0.21 97.60 ± 0.12
1 YP/X: product/biomass yield. YX/S:
2 Biomass/substrate yield. 3 YP/S: product/substrate yield. Data correspond to
the mean of three sample replicates with ± SD.
3. Discussion
For the microbial production of (+)-zizaene, significant product volatilization was observed when
the recombinant E. coli strain was cultured without extractants, similar to that observed with the
sesquiterpenes α-humulene [41]. Regardless of the low vapor pressure (5.1 kPa at 20 ◦C) and boiling
point (288 ◦C) of (+)-zizaene, the volatilization of (+)-zizaene could be explained due to its low aqueous
solubility (0.1289 mg L−1 [42]), which practically remains immiscible in the aqueous broth and tends
to volatilize. As a solution, we tested the LLPPC at shake flask scale and improved the (+)-zizaene
recovery and cell growth, reducing then the cell toxicity. Similar results were shown for the recovery
of amorpha-4,11-diene, where the titers from the LLPPC tests were 8.5-fold higher than the controls
without extractants [43]. Such improvements can be explained because the organic solvents extract the
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isoprenoids during culture due to hydrophobic interactions, and partition from the aqueous phase
(culture broth) as demonstrated in many terpene studies [1,44,45].
Accordingly, the Diaion HP20 obtained the highest (+)-zizaene recovery ratio from all tested
adsorbers. In comparison with the other adsorbers, Diaion HP20 has the largest pore size (290 Å)
and pore volume (1.3 mL g−1) and it is used commonly for the adsorption of relatively large
molecules such as small proteins. Although the sesquiterpene (+)-zizaene is not considered a large
molecule (204.35 g mol−1), the large pores from the Diaion HP20 could possibly favor the (+)-zizaene
adsorption. This idea could be supported due to the low recovery from the Lewatit 1064 MD,
which has the lowest pore size of all the tested adsorbers (50 Å). Similar to our findings, the Diaion
HP20 resin obtained the highest recovery ratio for the fragrant benzaldehyde (106.12 g mol−1) and
L-phenylalanine (165.19 g mol−1) in bioreactor cultivations of Pycnoporus cinnabarinus [46], as well as
for the prodigiosin-like red pigment (323 Da) from Serratia sp. KH-95 [47], whereas the Amberlite
XAD16 adsorber (pore size 200 Å) showed the lowest recovery for both cases.
Additionally, all of the tested adsorbers demonstrated higher cell growth when compared to
the negative control without extractants. Such results were expected since it is known that most
of the adsorbers do not affect cell growth due to their synthetic polymeric composition [37,48].
In addition, the low cell growth from the negative control suggests a toxic effect due to (+)-zizaene
accumulation, similar to the toxic effect of linalool and linalool oxides accumulation on the fermentation
of Corynespora cassiicola [27]. Eventually, further tests are required to measure the toxicity threshold of
(+)-zizaene in fermentations.
Concerning the screening of solvents for the desorption of (+)-zizaene, the results were as
expected, where solvents with log P values higher than 0.73 eluted the highest sesquiterpene amounts
due to their capability to trap hydrophobic compounds [15,19]. Although many studies used ethyl
acetate [11,25] for terpene desorption, in our case we chose isooctane (log P = 3.80) because of the
similar product recovery when compared to ethyl acetate but at a lower cost. In addition, isooctane
has been proven suitable for the recovery of other terpenes such as limonene-1,2-diol produced by
Rhodococcus erythropolis DCL14 [49]. Moreover, isooctane was used successfully for the extraction of
(+)-zizaene on in vitro biotransformation reactions, as shown in our previous report [10].
To recover efficiently the (+)-zizaene at bioreactor scale, distinct ISPR configurations were
integrated into the fermentation, using Diaion HP20 as adsorber and isooctane as elution solvent.
Although these were chosen due to their recovery performance, other factors such as their low cost
and ease for implementation were considered for the selection criteria.
Initially, the ERC improved the (+)-zizaene production 2.5-fold when compared to that of the
LLPPC at shake flask tests. Eventually, the minimal growth by feeding glucose maintained the acetate
levels at a minimum, allowing the fermentation to reach a higher cell growth (OD600 of 43.0), and
avoiding an overflow metabolism. Similar cell growth was also achieved by fed-batch fermentation
of a metabolically-engineered E. coli strain for the production of (-)-α-bisabolol, fed with glycerol
after 72 h of culture [14]. Besides, the external loop of the ERC allowed the semi-continuous product
recovery, reaching (+)-zizaene titers of 93.4 mg L−1. Such improvements have also been obtained by
the use of ERC in other terpenes studies, such as monoterpene carvone (225 mg L−1) [37] and diterpene
cembratriene-ol (78.9 mg L−1) [50].
The (+)-zizaene production was enhanced 2.2-fold further by the use of the IRC when compared
to the ERC. Besides, the (+)-zizaene amounts from cell-free media from the IRC were lower than the
ERC. This demonstrates a higher (+)-zizaene recovery ratio from the IRC (98.4%) than the ERC (94.6%),
which resulted in higher cell growth and soluble ZS protein synthesis, suggesting cell toxicity from
(+)-zizaene accumulation in the culture broth of the ERC. This could be explained due to the residence
time of the adsorbers on the culture broth, whereas in the ERC, the adsorbers have less time in contact
with the culture broth (recirculation rate 6 h−1) than in the IRC, in which it resides constantly. Similar
results were obtained for the production of prodigiosin-like red pigment from Serratia sp. KH-95,
where the ERC obtained lower amounts than the IRC due to the lower contact of the adsorbers in the
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culture broth [51]. Consequently, terpenes need to be recovered rapidly from the culture broth before
becoming volatilized. This was confirmed by the IRC+GS, in which less than 1% of the (+)-zizaene
amount was volatilized due to the efficient (+)-zizaene recovery from the adsorbers inside the vessel
(97.6%). Hence, the adsorption velocity plays an important role in the ISPR of terpenes.
The IRC showed lower (+)-zizaene amounts from the cells than the ERC; demonstrating no
correlation between cell growth and (+)-zizaene amount from cells. Possibly, the constant contact
of the E. coli cells with the Diaion HP20 adsorbers from the IRC could improve the secretion and
trapping of (+)-zizaene by an adsorption mechanism (chemisorption) as described in Figure 1. Similar
behavior was observed in the production of a prodigiosin-like red pigment, where the compound was
bound to the cell wall from Serratia sp. KH-95 and it was adsorbed towards the Diaion HP20 adsorbers,
dispersed in the culture broth [51].
The contribution of the (+)-zizaene recovery from the adsorbers on the off-gas was lower
than 1%, which demonstrates an efficient (+)-zizaene recovery from the adsorbers. For further
scale-up studies of sesquiterpenes, the gas stripping recovery could be unnecessary when the IRC
is used. Thus, the accumulative (+)-zizaene recovery from the IRC achieved titers of 211.1 mg L−1
and productivities of 3.2 mg L−1 h−1, which are similar to other IRC terpene bioprocesses, such as
fusicocca-2,10(14)-diene (43mgL−1, 0.6mg L−1 h−1) [11],α-humulene (60.2mg L−1, 2.5mg L−1 h−1) [41],
and carvone (198 mg L−1, 2.9 mg L−1 h−1) [37]. Moreover, our study demonstrated higher titers and
productivities when compared to other LLPPC terpene bioprocesses, such as patchoulol (50 mg L−1,
0.65 mg L−1 h−1) [52] valerenadiene (62 mg L−1, 1.3 mg L−1 h−1) [53], and farnesol (135.5 mg L−1,
2.8 mg L−1 h−1) [54]. Consequently, the use of IRC with solid extractants is a promising alternative
towards the scale-up of the microbial production of terpenes.
4. Materials and Methods
4.1. Materials and Chemicals
Chemicals used in this study were of analytical grade. Polymeric adsorbers were Amberlite®
IRA400 Cl, XAD4, XAD16N (Supelco, Bellefonte, PA, USA), Lewatit® 1064 MD (Lanxess, Cologne,
Germany), and Diaion HP20 (Mitsubishi Chemicals, Tokyo, Japan).
4.2. Strain and Pre-Cultures
The metabolically-engineered strain used in all the experiments of this research was the
multi-plasmid E. coli Tuner TZS+MevZS strain, as described in our previous report [9].
All pre-cultures were prepared in 5 mL LB broth with 30 mg L−1 kanamycin and 34 mg L−1
chloramphenicol from glycerol stocks, and cultivated at 37 ◦C in a rotatory incubator at 150 rpm.
For shake flask experiments, pre-cultures were grown overnight and inoculated to main cultures
consisting of 35 mL of a modified Aparicio defined medium (ADM, [9]) with 5 g L−1 glucose in
sealed glass-baffled shake flasks, to initiate at an OD600 of 0.1, and grown with the same conditions
as mentioned before. Induction was performed when cultures reached OD600 0.6–0.8 by lowering
the temperature to 20 ◦C and adding isopropyl-β-D-thiogalactoside (IPTG) to a final concentration of
0.5 mM.
4.3. Product Volatilization and LLPPC Experiments
Shake flask cultures without extractants and induced for 24 h were centrifuged for 20 min
(10,000 × g at 4 ◦C) and the supernatant was filtered through a 0.2 µm filter. Cell-free broth was
transferred to sterile shake flasks and incubated at 20 ◦C and 150 rpm. Samples were taken from the
cell-free broth, further extracted and terpene products were measured via gas chromatography coupled
with a flame ionization detector (GC-FID).
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For the LLPPC evaluation, cultures were prepared as in Section 4.2 and 10% isooctane (v/v) was
added promptly after the addition of IPTG. No extractant was added to the negative control. Cultures
were grown for 72 h and every 12 h samples were taken for growth kinetics and terpene analytics.
4.4. Screening of Polymeric Adsorbers
The testing of adsorbers was performed using an in vivo method as described by Halka [11].
For that, distinct polymeric adsorbers (Table 2) were conditioned by washing them with water,
isopropanol, isooctane, and finally water. After autoclaving shake flasks with 50 g L−1 of the respective
adsorbers, 35 mL of ADM was added and inoculated with pre-culture broth to an initial OD600 of
0.1. Growth conditions and induction procedures were according to Section 4.2 and samples were
analyzed after 24 h of induction. Terpene products were extracted from adsorbers, cell-free broth, and
cells according to Section 4.7.3. A negative control without extractants was included, in which only
cell-free broth and cells were analyzed. Identification of terpene products was carried out via gas
chromatography with mass spectrometry (GC-MS) and quantification of (+)-zizaene was carried out
via GC-FID. To measure the effect of the tested adsorbers on cell growth, the OD600 and the dry cell
weight (DCW) biomass were analyzed from the distinct resins. The (+)-zizaene recovery ratio from
adsorbers was calculated as the (+)-zizaene titer from adsorbers between the accumulative (+)-zizaene
titer (recovered from adsorbers, cells, and cell-free media). Data sets were analyzed by ANOVA
according to Section 4.8.
Table 2. Main properties of the polymeric adsorbers used for the in situ recovery of (+)-zizaene 1.
Properties Amberlite IRA400 Cl
Lewatit
1064 MD
Amberlite
XAD16N
Amberlite
XAD4
Diaion HP20
Particle size (µm) 600–750 440–540 560–710 490–690 250–800
Mean pore size (radius) (Å) 100 50 200 100 290
Surface area (m2 g−1) - 800 800 750 590
Pore volume (mL g−1) - 1.2 0.55 0.5 1.3
Particle density (mg L−1) 1.06–1.09 1.02 1.02 1.02 1.01
Functional groups Dimethyl ethanol ammonium - - - -
Ionic form Basic anion exchange Non-ionic Non-ionic Non-ionic Non-ionic
1 Information obtained from supplier data sheets.
4.5. Evaluation of Organic Solvents for the (+)-Zizaene Desorption
Organic solvents with a high log P value were evaluated for the desorption of (+)-zizaene
comprising decane, dodecane, isooctane, ethyl acetate, isopropanol, acetonitrile, and pentane (Table
S1). The Diaion HP20 adsorbers were prepared as described in Section 4.4 and the tested organic
solvents were used respectively for the conditioning of adsorbers.
Microbial cultures were prepared as described in Section 4.2 without extractants and after 48 h of
cultivation, 2 mL of culture broth was transferred to sterile vials with 0.5 g of Diaion HP20 adsorbers.
Afterwards, vials were incubated for 4 h at 20 ◦C and 150 rpm. Furthermore, the culture broth
was discarded and adsorbers were extracted with the tested solvents as described in Section 4.7.3
(+)-Zizaene concentrations were measured via GC-FID and statistical analyses were carried out
according to Section 4.8.
4.6. Bioreactor Cultivations with In Situ Recovery of (+)-Zizaene
Pre-cultures were prepared as described in Section 4.2, followed by a third pre-culture that
consisted of a 100 mL ADM shake flask culture. After 12 h of cultivation, pre-cultures were inoculated
to bioreactors to an OD600 of 0.3–0.4.
2 L stirred-tank bioreactors (Biostat A+, Sartorius, Göttingen, Germany) were used for the
cultivations, with 1.5 L working volume consisting of an ADM with 5 g L−1 glucose and respective
antibiotics. The pH was controlled automatically with 1 M HCl and 25% NH4OH (v/v) solutions.
The Diaion HP20 adsorbers were conditioned according to Section 4.4 with isooctane as the solvent.
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4.6.1. IRC Bioreactor
The IRC was prepared with 50 g L−1 of Diaion HP20 dispersed in the culture broth, inside the
bioreactor vessel. The IRC with gas stripping (IRC+GS) was carried out similarly to the IRC and
a 200 mL columnwas added to the off-gas line loaded with 75 g of Diaion HP20, followed by an ethanol
trap cooled with dry ice and two 0.2 µm sterile filters.
4.6.2. ERC Bioreactor
The ERC was configured without extractants inside the bioreactor vessel, and the culture broth
was recirculated to an external recovery loop through a stainless steel EBA column of 200 mL inner
volume with 75 g of Diaion HP20 as the fluidized bed. For that, a silicone tubing of 4 mm inner
diameter (i.d.) was connected to the EBA column (4.6 cm i.d., 12 cm length for inner chamber) with
outlets of 4 mm i.d. and a sampling port on the lateral side. The EBA column had two stainless steel
meshes (6 cm diameter of 500 µm) on both terminal sides, fixed with gaskets to recirculate cells and
media through the resins while retaining the adsorbers inside the column. The external loop operated
continuously at a flow rate of 150 mL min−1 (recirculation rate = 6 h−1) by a SciLog Expert peristaltic
pump (Wisconsin, USA).
For all bioreactor configurations, the batch cultivation settings were dissolved oxygen >30%,
agitation 400–700 rpm, temperature 37 ◦C, pH 7.0, and gas flow rate 1.0 vvm. When the glucose was
exhausted, the fed-batch stage was initiated by dropping the temperature to 20 ◦C and initiating the
feeding. The fed-batch medium was composed of glucose 100 g L−1, NaCl 1.2 g L−1, CaCl2 0.14 g L
−1,
MgSO4·7H2O 0.6 g L
−1, FeSO4·7H2O 0.001 g L
−1, and CuSO4·5H2O 0.001 g L
−1 with respective
antibiotics. The induction was performed after 1 h of feeding by adding 0.5 mM IPTG and in the case
of the ERC, the recirculation towards the external loop was activated. Samples for growth kinetics,
soluble ZS protein, and terpene analysis were properly taken, measured according to Section 4.7, and
plotted with Origin 9.5.5. (Northampton, MA, USA).
4.7. Analytical procedures
4.7.1. Growth Kinetics Analysis
To assess the growth kinetics from cultivations, the cell growth was analyzed by measuring
the optical density from fermentation samples at 600 nm using a Biochrom Libra S50 UV-Vis
spectrophotometer (Cambridge, UK) and biomass by the dry cell weight method. Glucose consumption
was measured from cell-free broth samples with the Biochemistry Analyzer YSI 2900 (Yellow Springs,
Greene County, OH, USA). Acetate was measured via high-pressure liquid chromatography as
described elsewhere [55].
4.7.2. Soluble ZS Protein Fraction Analysis
Broth samples were normalized to an OD600 of 2.0 and extracted as described in our previous
report [9]. Soluble ZS protein fractions were analyzed on a 10% sodium dodecyl sulfate polyacrylamide
gel electrophoresis with a calibration curve of bovine serum albumin. Quantification of soluble ZS
protein was performed by a densitometric method [56,57], measuring the intensity of the ZS protein
bands at 78 kDa from stained gel images by the GelAnalyzer 2010 (developed by Istvan Lazar).
4.7.3. Sample extraction
Samples for terpene analyses were extracted from distinct sources during cultivations. Samples
from cell-free media, known also as supernatant, were prepared by transferring 2 mL of culture broth
to 10 mL glass vials. After centrifugation for 5 min at 10,000× g, the supernatant was transferred
to other glass vials and extracted vigorously thrice with 0.5 mL of isooctane. Organic phases were
obtained by centrifugation and transferred to GC vials for (+)-zizaene measurements via GC-FID.
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Samples from cells were prepared similar to Section 4.7.2. After extracts were ultrasonicated,
300 µL of isooctane was added to 300 µL of cell extract and extracted vigorously. Organic phases were
separated by centrifugation and transferred to GC vials for (+)-zizaene measurements via GC-FID.
Samples from adsorbers were extracted vigorously three times by transferring 300 mg of resins
to 10 mL glass vials and adding 1 volume of isooctane (or tested solvent for Section 4.5). Organic
phases were transferred to GC vials for further product identification via GC-MS and (+)-zizaene
quantification via GC-FID.
4.7.4. GC-MS analysis
For the identification of terpene products from the adsorber screening test (Section 4.4), the
extracted samples were analyzed by an Agilent 7890B GC-MS system (Santa Clara, CA, USA).
Samples of 0.5 µL were injected into the GC-MS equipped with a VF-WAXms capillary column
(0.25 mm i.d. × 0.25 µm thickness × 30 m length; Agilent, Santa Clara, CA, USA) by the on-column
mode with helium 5.0 as the carrier gas at a constant gas flow of 1 mL min−1 and injector temperature
of 230 ◦C. The oven program comprised 3 steps: (1) 40 ◦C, 3 min; (2) 40–230 ◦C, 10 ◦C min−1; (3) 10 min
hold. The scan range was set to 33–300 m/z and the ionization energy to 70.0 eV. Product identification
was carried out by comparing mass spectra of samples with authentic standards obtained from the
VEO and references from the mass spectral NIST 14 database.
4.7.5. GC-FID analysis
Quantification of (+)-zizaene was done with a GC-2010 plus Shimadzu system coupled with
a flame ionization detector (Kyoto, Japan). Samples of 1 µL were injected to the GC-FID with an injector
temperature of 240 ◦C on splitless mode. Oven program was set with the following steps: (1) 40 ◦C,
20 s; (2) 40–200 ◦C, 10 ◦C min−1; (3) 0.5 min hold; (4) 200–230 ◦C, 30 ◦C min−1; (5) 2 min final hold.
The quantification of (+)-zizaene was calculated as α-cedrene equivalents by a calibration curve of
α-cedrene (standard grade) due to the lack of a commercial (+)-zizaene standard, as demonstrated in
a previous report [10].
4.8. Statistical Analysis
Data from Sections 4.4 and 4.5 were analyzed by analysis of variance (ANOVA) and mean
comparison tests to assess statistical differences. Adsorbers and organic solvents were used as factors
respectively and (+)-zizaene titer was used as the response variable. Data sets were analyzed by
Minitab 16 (Pennsylvania, USA) with the ANOVA module and the Bonferroni test was applied for
mean comparison test with a 95% confidence level.
5. Conclusions
The results achieved in this study demonstrated the improvement of the microbial production
of (+)-zizaene compared to previous studies by enhancing the recovery of (+)-zizaene. Initially, the
loss of (+)-zizaene by volatilization was measured and further reduced by LLPPC at shake flask scale.
Furthermore, the Diaion HP20 resin obtained the highest (+)-zizaene recovery after screening distinct
adsorbers by SLPPC. After evaluating distinct solvents for the desorption process, the isooctane was
selected as a suitable eluent and the SLPPC reached (+)-zizaene titers comparable to those obtained
by the LLPPC. The scale-up to bioreactors by integrated product recovery configurations improved
dramatically the (+)-zizaene production, whereas the IRC demonstrated higher (+)-zizaene titers
(211.13 mg L−1) and productivities (3.2 mg L−1 h−1) than the ERC. Consequently, the successful
application of ISPR proved a greener extraction method, which reutilizes the extractant material
(polymeric adsorbers), reduces the number of extraction reagents (only one solvent is required), reduces
the energy input and quantity of chemical wastes, and improves the recovery ratio of (+)-zizaene
over 98%.
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5. Concluding remarks 
The microbial production of terpenes is a promising alternative towards a sustainable supply by 
renewable resources. Although much progress has been achieved in the metabolic engineering of 
many terpenes by the academic and industrial sector, few are the cases which have reached the 
industrial scale. The knowledge developed from this dissertation provides new insights in the 
biotechnological production of fragrant sesquiterpenes. The main concluding remarks of this 
research are summarized as follows:    
Most plant-based TPS are expressed poorly in E. coli, leading to inclusion body formation. To 
circumvent such formation, the ZS is overexpressed with a fusion SUMO domain that increases 
solubility. Consequently, most of the ZS protein is produced in the soluble fraction and in an 
active form, demonstrating a high catalytical selectivity towards E,E-FDP, yielding 90% (+)-
zizaene (main product) and 8.5% β-acoradiene (side product). The optimal reaction conditions 
are found to be pH 7.5 and 36 °C, showing a similar pH as found in the cytosol from plant cells. 
Interestingly, the ZS follows a substrate inhibition kinetic model, which is believed to play a role 
in the regulation of terpene biosynthesis in plants, triggered by abiotic factors.  
Concerning the substrate specificity, ZS is a promiscuous TPS for monoterpenes substrates (GPP 
and NPP), leading to the formation of 8 distinct acyclic, cyclic and hydroxylated monoterpenes. 
On the contrary, ZS is a high-fidelity TPS for sesquiterpene isomer substrates (E,Z-FDP and Z,E-
FDP), yielding only 1 acyclic and 3 acyclic/cyclic sesquiterpenes respectively.  
The catalyzation of E,E-FDP by ZS is very stable at a broad range of pH values and temperatures, 
as demonstrated by the constant product ratio through the tested conditions. Further in silico 
docking models revealed that the residue composition from the J-K and A-C loops contributed to 
the stabilization of the closed conformation of ZS, capable of standing the pH and temperature 
variations.  
The metabolic engineering of the (+)-zizaene biosynthetic pathway was performed in E. coli as 
host. As a proof of concept, (+)-zizaene can be produced by overexpressing the SUMO-fused ZS 
and utilizing the FDP supply from the endogenous MEP-pathway from E. coli, but at lower titers.  
Thus, the engineering of the exogenous MEV-pathway is necessary to increase the FDP supply. 
However, overexpression of the MEV-pathway and the ZS gene into a single polycistronic vector 
produces still low (+)-zizaene titers due to the decline of the ZS supply, in part because of the 
design of the MEV operon and the strength of the lacUV5 promoter. After testing distinct 
promoters for the ZS gene with mono-cistronic plasmids, the T7 promoter was found to increase 
the ZS supply, which leads to the increase of the (+)-zizaene titers. At this point, the ZS is still the 
bottleneck of the biosynthetic pathway. This was demonstrated by increasing the ZS supply 
further by overexpressing a second copy of the ZS gene. In consequence, the overexpression of 
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the ZS gene into two distinct plasmids under the control of two promoters is an optimal 
alternative to improve the (+)-zizaene titer. 
Optimization of the fermentation conditions by testing media, pH, temperature, induction and   
E. coli B strains further improves the (+)-zizaene titer. The most relevant factor is the nitrogen 
concentration in the media, which enhances the protein synthesis, resulting in a higher cell 
growth and soluble ZS protein amounts. Moreover, the use of the E. coli Tuner(DE3) B strain 
improves the (+)-zizaene production because it reduces the overexpression of unnecessary 
recombinant proteins, reducing the metabolic burden of the cells. 
Further development of the (+)-zizaene bioprocess requires an efficient product recovery method 
integrated to fed-batch cultivations at bioreactor scale. Initially, the loss of (+)-zizaene by 
volatilization was confirmed in cultures without extractants, and the application of LLPPC 
improves the (+)-zizaene recovery 4-fold from culture broth. Furthermore, the Diaion HP20 is the 
best polymeric adsorber for SLPPC with similar recovery ratio as the LLPPC. Because of the ease 
of resin removal, reuse and non-emulsion formation, the SLPPC is preferred as ISPR of             
(+)-zizaene and evaluated by testing distinct bioreactor configurations. As a result, (+)-zizaene 
recovery from ERC enhances the (+)-zizaene titer 2.5-fold higher than the LLPPC. Application of 
IRC further improves the (+)-zizaene titer 2.2-fold and additional IRC+GS fermentation test 
confirmed the efficient (+)-zizaene recovery from IRC due to the low (+)-zizaene amount 
recovered from the off-gas. Moreover, the IRC demonstrated the highest (+)-zizaene recovery 
due to a higher adsorption velocity when compared to that of the ERC. In consequence, the IRC 
is the most suitable method for (+)-zizaene recovery in HCDC at bioreactor scale, reaching       
(+)-zizaene titers of 211.13 mg L−1 and productivities of 3.2 mg L−1 h−1.  
Finally, this thesis contributes towards the microbial production of the fragrant sesquiterpene 
khusimol by the characterization of the ZS, the metabolic engineering of (+)-zizaene and the 
enhanced (+)-zizaene production by integrating fermentation and product recovery. Overall, this 
study provides new insights in the bioprocess development for the microbial production of 
fragrant terpenes. 
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6. Outlook and recommendations 
The microbial production of (+)-zizaene can be improved further by applying protein 
engineering to the ZS, which could augment its catalytical activity. Eventually, improved ZS 
variants can be developed by site-directed mutagenesis from residues in the active site, 
identified in chapter 1. Additionally, the application of other protein engineering methods such 
as directed evolution should also be considered.  
Raising the ZS supply in combination with the increase of the FDP supply could boost the 
production of (+)-zizaene. This can be achieved by engineering the MEV-pathway by testing 
distinct FDP synthases from distinct organisms, as demonstrated for the metabolic engineering 
of the sesquiterpene longifolene in E. coli [60]. Eventually, other enzymes belonging to the   
MEV-pathway could also be considered for further tests. Engineering the (+)-zizaene 
biosynthetic pathway in yeasts could eventually boost the terpene production, as shown in other 
cases [31] and should be considered for further experiments. 
Concerning the in situ recovery of (+)-zizaene, the ERC process could be improved further. 
Although the IRC showed higher recovery than the ERC, the latter holds a higher potential to be 
applied at larger scales. Therefore, the optimization of the EBA variables, such as recirculation 
rate, adsorber amount and degree of bed expansion (sedimented bed height) could considerably 
improve the recovery rate, as observed by the acetate recovery for the production of alpha-
interpheron-2b in E. coli [75]. On the other hand, the IRC could be improved by devising a fixed 
adsorption basket such as that described for the production of prodigiosin-like pigment from 
Serratia sp. KH-95 [71]. Among the advantages of this method are stabilizing the fermentation 
parameters (pH, pO2 and stirring), avoiding clogging of valves and preventing damage of 
adsorbers due to shear forces.  
Although the improvement of the (+)-zizaene production by metabolic engineering and product 
recovery is of interest, the production of the final compound, the fragrant khusimol, is of greater 
relevance. As a starting point, the enzymatic hydroxylation of (+)-zizaene towards khusimol 
should be addressed.  
Currently, there is a patent that describes two cytochrome P450 monooxygenases capable of such 
hydroxylation [49]; however, our results overexpressing these P450 enzymes in E. coli and 
Chlamydomonas sp. demonstrated a different catalytical specificity (unpublished results). 
Consequently, the screening of other monooxygenases from the Ch. zizanioides is considered the 
recommended approach to fulfill this enzymatic hydroxylation. Taking into account the 
published transcriptomes from the vetiver grass [76,77], a bioinformatic approach could be used 
to screen RNA sequences from putative cytochrome P450 monooxygenases and test them 
experimentally by codon optimized synthetic genes, overexpressed in microbes.  
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Furthermore, in vitro hydroxylation assays can be applied to confirm the catalyzation to 
khusimol by the P450 enzyme candidates. Once the positive hydroxylating enzymes are 
obtained, the bioprocess can be developed by the following alternatives: 
6.1. Whole-cell biocatalytical system: 
Positive cytochrome P450 monooxygenases for khusimol formation could be engineered into the 
microbial platform developed in this thesis and could be constructed a whole-cell biocatalytical 
E. coli strain able to produce khusimol from a carbon source. This could be engineered by cloning 
the P450 gene downstream the ZS gene in the pETZS plasmid with an IRES in between and co-
transforming it with the pMev plasmid into the Tuner E. coli strain. Alternatively, cloning the 
P450 gene and the ZS gene into a single vector with two promoters, such as the pETDuet 
(Novagen), should provide a stronger overexpression.  
Once the proof of concept for the khusimol production is reached, the bioprocess could follow a 
similar strategy as chapter 3, to test distinct ISPR configurations for the in situ recovery of 
khusimol in fed-batch bioreactors. 
6.2. In vitro biotransformations: 
Because of the low titers reported from the microbial production of hydroxylated sesquiterpenes 
[78,79], an alternative could be the in vitro biotransformation of (+)-zizaene to khusimol in 
reactors. For this method, the substrate (+)-zizaene would be produced by using the bioprocess 
developed in this thesis. Afterwards, the cytochrome P450 monooxygenases would be produced 
and purified similar to the procedure of the ZS. After the purification of both (+)-zizaene and 
P450 enzyme, the in vitro biotransformation reactions could be carried out by incubating both 
under controlled conditions into a reactor to yield khusimol and further extract and purify it via 
flash chromatography.  
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